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Abstract 
Background Several previous studies have shown that black patients receive coronary 
reperfusion procedures less often than white patients after acute myocardial infarction (AMI). 
Despite this well documented difference, no evidence has shown a decisive difference in 
morality rates between black and white AMI patients.  
Purpose The purpose of this review is to systematically collect and analyze the current evidence 
that evaluates racial differences in mortality caused by racial differences in revascularization 
procedure use between black and white patients presenting with AMI. 
Methods A systematic review was conducted by a single reviewer using a MEDLINE literature 
search to identify observational studies that evaluate black and white patient differences in 
revascularization procedures and mortality after AMI. A total of 86 citations were reviewed, 42 
articles were retrieved, and 11 articles were included from the MEDLINE search. An additional 
3 articles were included following a reference list review. Included studies were evaluated for 
design quality using an abbreviated form of the Scottish Intercollegiate Guidelines Network 
(SIGN) methodological checklist for cohort studies.  
Results 8 of 10 studies evaluating PTCA rates showed that black patients with AMI receive 
PTCA less often than white patients. 9 of 10 studies evaluating coronary artery bypass graft 
surgery (CABG) rates showed that black patients with AMI receive CABG less often than white 
patients. No studies within the review showed a statistically significant difference between black 
and white patients for in-hospital, 30-day, 1-year, 2-year, 3-year, or 5-year mortality rates. 1 
study showed a statistically significant difference of age-adjusted mortality rate per 100 person 
years for black men (HR 1.34 95% CI 1.18-1.52) and black women (HR 1.22 95% CI 1.06-1.40) 
compared to white men.  
 3 
Conclusion Despite evidence to support racial differences in revascularization procedures after 
AMI, the collection of evidence within this review does not indicate a racial difference in 
mortality. The similarities in mortality despite differences in standards of care may be explained 
by a process of selection of healthier black patients secondary to higher rates of out of hospital 
AMI death among black patients.  
 
Introduction 
Background and Epidemiology 
An estimated 565,000 first-time myocardial infarctions and 300,000 recurrent attacks 
occur each year in the United States (US), leading to an estimated 157,559 deaths annually.
1 
Acute ST segment elevation myocardial infarction (STEMI) occurs when a thrombus forms on a 
ruptured coronary atheromatous plaque, leading to the occlusion of a coronary artery.
2  
Myocardial infarction occurs when the resultant myocardial ischemia is sufficient to cause cell 
death.
2  
The primary goal of treatment is to reestablish the patency of the occluded coronary 
artery, strong evidence shows that expeditious restoration of flow in the obstructed infarct artery 
is a key determinant of short-term and long-term outcomes.
3 
  
Primary percutaneous transluminal coronary angioplasty (PTCA) and coronary artery 
bypass graft surgery (CABG) are both available treatment options to reestablish coronary blood 
flow, and have been shown to improve survival and decrease symptoms in appropriate patients.
3-
7 
 PTCA compared to fibrinolytic therapy has been shown to provide better short-term (4-6 
weeks) outcomes including lower rates of death (7% vs 9%), non-fatal reinfarction (3% vs 7%), 
stroke (1% vs 2%) and the combined endpoint of death, reinfarct, and stroke (8% vs 24%) for 
patients presenting with AMI.
7 
 These differences were maintained at long term follow up (6-18 
 4 
months). CABG for primary reperfusion during STEMI has largely been superseded by 
fibrinolysis and PTCA,
8
 however, CABG is beneficial in AMI patients with associated valve 
disease, mechanical complications, left main or three-vessel coronary disease, coronary anatomy 
unsuitable for other forms of therapy, or ischemia refractory to non-surgical intervention.
8 
  
The American College of Cardiology and American Heart Association (ACC/AHA) Task 
Force found sufficient evidence from multiple randomized trials that the benefits of percutaneous 
coronary intervention (PCI) for STEMI patients greatly outweigh risk when performed under 
appropriate conditions (Class I level of evidence A). According to the official ACC/AHA 
recommendation, PCI is favored over thrombolytics when the procedure is not contraindicated, 
immediately available, completed within 12 hours of symptom onset, performed in a timely 
fashion, and performed by skilled persons in an appropriate laboratory environment.
9 
The task 
force found limited evidence that showed that the benefits of emergency CABG greatly outweigh 
risk for patients with persistent or recurrent ischemia refractory to medical therapy and who have 
appropriate coronary anatomy and are not candidates for PCI or fibrinolytic therapy. According 
to the official ACC/AHA recommendation, CABG should be performed for patients under these 
conditions (Class I level of evidence B). Other conditions for which CABG is recommended 
include patients who suffer AMI complicated with cardiogenic shock who are under the age of 
75 and develop shock within 36 hours of STEMI, have severe multivessel or left main disease, 
and are capable of receiving the procedure within 18 hours of shock onset and patients with life-
threatening ventricular arrythmias in the presence of >50% left main stenosis or triple vessel 
disease.
9 
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Racial Differences in AMI Care 
Despite the documented benefits of revascularization procedures after AMI, several 
studies have shown racial differences in the use of both PTCA and CABG between black and 
white patients presenting with AMI.
10-17 
Blacks are less likely than whites, in some studies nearly 
half as likely, to receive revascularization procedures when presenting with similar acute cardiac 
symptoms (Table 1: Studies Indicating Racial Differences in PTCA and CABG Use after AMI). 
This procedural difference has been reported in surveys of databases consisting of Medicare 
cohorts, Veterans Affairs Medical Center cohorts, single center cohorts, and in state-based 
registries.
18 
The difference in rates has been shown to persist after adjusting for disease severity 
and socioeconomic indicators,
19
 supporting the existence of a true racial difference in 
revascularization procedure use.   
A racial difference in health care is an observed racial variation in health care use by 
race.
20 
The terms racial difference and racial disparity are commonly used interchangeably within 
the medical literature, however, the 2 terms are not synonymous. A racial disparity of care is a 
difference in appropriate treatment use that is associated with poorer outcomes and is not 
attributable solely to patient factors including disease burden and treatment preference.
20 
A racial 
difference in care may or may not be associated with different outcomes or attributable to patient 
factors.  
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Data supporting racial differences in procedural rates alone must be interpreted carefully. 
Equal or unequal procedural use is not considered an appropriate measure for which to judge 
racial differences in health care because it presupposes equal need, preferences, and benefit 
across racial groups.
20 
Increasing procedural use of one population to equal that of another 
assumes that higher rates of health care use will improve patient outcomes, which is not always 
true.
20 
 
 A more appropriate goal of care is the establishment of clinical equity. Clinical equity 
allows measured racial differences and inequalities in health care to be evaluated within a 
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clinical context. An “equitable distribution of health care” can be defined as a distribution in 
which clinical need is the primary determinant of equal opportunities for patients to use health 
care resources.
20 
Within this framework, other determinants of health care opportunity including 
social, political, cultural, historical, and environmental factors may unjustifiably alter 
opportunity, leading to an inequitable distribution of care.
21 
 
The distinction between inequality and inequity requires examination of the various 
determinants of health care access.
21 
This distinction is an important step in evaluating the 
significance of a health care difference, and is vital toward developing further research and 
interventional targets. Racial inequalities in care found to be consistent with patient preference or 
needs may be seen as acceptable differences in the distribution of health care. Racial inequities in 
healthcare distribution indicate unjust patterns of treatment opportunity and allocation, and 
consequently, would require necessary intervention to assure appropriate access to care. 
Purpose of Paper 
The evidence discussed thus far suggests that prompt PTCA produces better clinical 
outcomes than non-invasive therapies, CABG in select patient populations is beneficial as a 
reperfusion strategy post-MI, and that black patients presenting with AMI are less likely to 
receive revascularization procedures compared to whites. The conclusion that blacks suffer worst 
outcomes after AMI because they are less likely to receive PTCA or CABG would reasonably 
follow from this evidence, however, studies conducted to directly measure outcome differences 
within this population have not consistently shown any exist. Currently no decisive outcome 
difference can be attributed to the difference in revascularization procedure use between blacks 
and whites. Conversely, despite several studies, no decisive evidence exists that has proven that 
no real difference exists either.  
 8 
The lack of scientific consensus on the racial differences in revascularization use and 
related outcomes has denied the ability to evaluate this racial difference within a clinical context. 
This racial difference cannot be truly classified as a racial disparity in health care without 
evidence of related adverse health consequences, and therefore, the necessity of intervention 
cannot be accurately assessed. The purpose of this review is to systematically collect and analyze 
the current evidence that evaluates racial differences in outcomes caused by racial differences in 
revascularization procedure use between black and white patients presenting with AMI. The 
direction of future research and interventional efforts will be greatly benefited if more is known 
about the clinical significance of this topic. 
 
Methods 
 The focus populations for this review are Black/African American and White/Caucasian 
American patients suffering AMI in the United States between 1990 and 2007. The interventions 
of interest are coronary revascularization procedures (PTCA and CABG) performed as initial 
treatment for AMI. The time period 1990-2007 was selected because it coincides with the 
development and spread of primary PTCA as a common treatment option for AMI patients in the 
Unites States. The primary outcome of interest for the review is patient death/mortality. 
Reviewed studies will include prospective and retrospective cohort studies written in English and 
published between 1990 and 2007. Cohort studies were selected because the primary focus of the 
review is racial differences in procedure use and resulting effects on health outcomes in actual 
practice. Randomized trials were not included because experimental procedural rates would not 
be reflective of actual rates according to race, and thus produce population outcomes inconsistent 
with those seen in clinical practice.  
 9 
 A MEDLINE search was conducted on May 14, 2007 with the assistance of a systematic 
literature review specialist made available through the University of North Carolina at Chapel 
Hill Health Science Library. The population keyterms used for the search were African-
Americans or African Continental Ancestry or Black. The population was further specified using 
the keyterms heart attack or “myocardial infarct” or AMI. The intervention keyterms used for 
the search were percutaneous transluminal coronary angioplasty, angioplasty[ti], 
revascularization[ti], ptca[ti], coronary artery bypass and CABG[ti]. To identify studies that 
focused on race, the keyterms race[ti], racial[ti], “racial differences”, “racial disparities”, 
“racial disparity”, “racial variation”, “racial variations”, and “race-specific models” were 
used. To identify studies that focused on treatment mortality outcomes, the key terms treatment 
outcomes, outcome assessment, outcome[ti], mortality, survival[ti], and death[ti] were used.  
No previous reviews specifically evaluating racial differences in coronary procedure 
utilization and mortality were identified. The reference lists of the primary studies that were 
ultimately included in this review were reviewed for potential articles of interest.  
Discussions were held regarding the handsearching of medical journals as well as the 
searching of results of studies published in formats not indexed in major databases (“grey 
literature”). After consultation with an experienced research expert, it was concluded that this 
topic has a fairly extensive history of published peer reviewed studies accessible through 
electronic indexes, and further searching of published journals and “grey literature” for this 
review would be provide a low yield of contributory studies.   
Following the completion of the search for relevant research articles, a single reviewer 
selected studies to be included in the review based on predefined inclusion and exclusion criteria. 
Selection criteria were applied during an initial title and abstract review. The full text of articles 
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found relevant during the initial title and abstract review were collected and reviewed for 
possible inclusion. It is recognized that the use of a single reviewer increases the risk of bias in 
the selection of articles; however, the work force and time limitations of the review did not 
permit more than one reviewer to work on this project. The inclusion and exclusion criteria were 
discussed in detail with an experienced researcher prior to the selection process, and were 
precisely defined to help decrease the chance of selection bias.  
Inclusion Criteria 
Population: Studies focusing on Black/African-American and White/Caucasian patients 
diagnosed with AMI.  
Intervention: Studies focusing on coronary revascularization procedures (PTCA and CABG) 
used as initial management of AMI.  
Outcome: Studies comparing death/mortality between Black/African-American and 
White/Caucasian patients diagnosed with AMI.  
Study Design: Prospective cohort studies and retrospective cohort studies. 
Exclusion Criteria 
Population: Studies with non-black patient populations, patients not presenting with AMI, 
patients presenting with angina or unstable angina. Studies that do not directly compare 
Black/African-American and White/Caucasian patient characteristics, procedure use, and 
outcomes.  
Intervention: Studies of non-coronary revascularization treatments. 
Outcome: Studies whose outcomes are not related to death/mortality. Outcomes that are not 
compared to White/Caucasian patients with AMI. 
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Study design: Trials that are not prospective or retrospective cohort studies. Randomized control 
trials, non-English language studies, studies of non-US populations, and studies before Jan. 
1990.  
Content Review and Quality Assessment 
 Studies included in the review were individually assessed for content and design quality. 
Work force and time limitations allowed only a single reviewer with support from a research 
expert to assess design quality. It is recognized that the use of a single reviewer may lower the 
validity and reliability of the results.  
Each study was evaluated for potential selection bias, potential measurement bias, 
potential confounding, internal validity, and external validity. Analysis included assessment of 
group selection and comparison, distribution of prognostic factors, reliability of intervention 
measurements, reliability of outcome measurements, masked outcome assessment, drop out 
rates, and overall internal validity of outcomes. Special consideration toward the validity and 
reliability of measures of race/ethnicity and mortality were taken within the review.  
An abbreviated form of the Scottish Intercollegiate Guidelines Network (SIGN) 
methodological checklist for cohort studies was used to assess the comparability of subjects, 
exposure or intervention, outcome measurement, and statistical analysis. These four domains 
have been previously selected by the Agency for Healthcare Research Quality as essential for 
high performing quality assessment tools of observational studies.
22 
An additional domain was 
added to the checklist to evaluate the validity and reliability of race/ethnicity measures. 
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MEDLINE Electronic Search 
86 Articles 
Initial Title and Abstract Review 
Excluded 44 Articles 
4 
Full Text Review 
Excluded 31 Articles 
Total  
14 Articles Selected 
 
Reference Search 
Included 3 Articles 
 
Figure 1: Selection Flow Chart 
Results 
Study Search and Selection  
The MEDLINE search identified 86 articles. The initial title and abstract review led to 
the exclusion of 44 articles. The full references and reasons for exclusion of these articles are 
provided in the Catalog of Articles Excluded after Title and Abstract Review (Appendix A). The 
full texts of the remaining 42 articles were reviewed. This review led to the exclusion of 31 
articles. The full references and reasons for exclusion of these articles are provided in the 
Catalog of Articles Excluded after Full Text Review (Appendix B). A reference list review led to 
the selection of 3 additional studies. Full references of the selected articles from the electronic 
database and reference list search are provided in the Catalog of Selected Articles (Appendix C). 
The selection process is summarized in Figure 1.  
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Methodological Quality Assessment 
 Full article reviews containing detailed descriptions of study populations, measurement 
tools and databases, potential selection bias, potential measurement bias, potential confounding, 
statistical analysis and results are in included in Appendix D. Quality assessment results are 
listed in the Quality Assessment Table.  
The studies selected for this review consisted of 11 retrospective and 3 prospective cohort 
studies. Black and white comparison groups within all 14 studies differed significantly according 
to several variables other than revascularization procedures. The primary outcomes for all studies 
were well defined. There were 2 studies (Ding 2003; Iribarren 2005) that described the validity 
and reliability of appropriate race/ethnicity measures. The remaining 12 studies did not 
sufficiently describe these measures. There was 1 study (Petersen 2002) that reported the 
reliability of measures of exposure (revascularization procedures). There were 2 studies 
(Conigliaro 2000; Iribarren 2005) that adequately provided evidence from other sources that 
demonstrated that the measures of outcome (mortality) assessment are valid and reliable. The 
main potential confounders (age, sex, comorbidity, disease severity, hospital characteristics, and 
socioeconomic status) were adequately identified and considered in 4 studies (Conigliaro 2000; 
Petersen 2002; Gregory 1999; Peterson 1994). Confidence intervals during statistical analysis 
were sufficiently provided in 9 studies (Barnhart 2006; Ford 2000; Conigliaro 2000; Maynard 
1997; Petersen 2002; Gregory 1999, Palmeri 2005; Iribarren 2005; Ding 2003; Peterson 1994). 
There were 10 studies (Barnhart 2006; Ford 2000; Conigliaro 2000; Maynard 1997; Maynard 
1991; Mickelson 1997; Taylor 1998; Palmeri 2005; Giles 1995; Ding 2003) that were rated 
poorly for the ability to minimize risk of bias or confounding, and received the “-” coding on the 
SIGN scale used to complete the Quality Assessment Table. There were 4 studies (Petersen 
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2002; Gregory 1999; Iribarren 2005; Peterson 1994) that were given an intermediate grade 
between poor/adequate for ability to minimize bias and confounding, and received the “-/+” 
coding on the SIGN scale. No studies received the “+” or “++” grading for the ability to 
minimize bias and confounding. None of the reviewed studies, after considering clinical context 
and methodology, were judged to show a certain overall effect on mortality due to specific 
differences in cardiac revascularization procedure exposure.   
PTCA Procedure Rates  
There were 10 articles (Barnhart 2006; Ford 2000; Conigliaro 2000; Maynard 1997; 
Maynard 1991; Mickelson 1997; Petersen 2002; Taylor 1998; Giles 1995; Peterson 1994) that 
evaluated individual procedural rates for PTCA for both black and white patient populations. Of 
these 10 articles, a total of 8 (Barnhart 2006; Ford 2000; Conigliaro 2000; Maynard 1997; 
Maynard 1991; Giles 1995; Ding 2003; Taylor 1998) showed a statistically significant difference 
between black and white patients in the use of PTCA. The remaining 2 articles showed no 
statistically significant difference in PTCA rates according to race (Mickelson 1997; Petersen 
2002). It is worth noting that the Mickelson et al. study did show a trend toward a racial 
difference, but a small black and white patient population of 316 patients may have limited the 
ability to achieve statistical significance.  
CABG Procedure Rates  
 There were 10 articles that evaluated individual CABG rates according to race (Barnhart 
2006; Ford 2000; Conigliaro 2000; Maynard 1997; Maynard 1991; Mickelson 1997; Petersen 
2002; Taylor 1998; Giles 1995; Peterson 1994). Whites were shown to receive CABG at 
statistically significant higher rates than blacks in 9 of these studies (Barnhart 2006; Ford 2000; 
Conigliaro 2000; Maynard 1997; Maynard 1991; Petersen 2002; Taylor 1998; Giles 1995; 
Peterson 1994). The Mickelson study showed a trend toward a difference in procedure use that 
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did not achieve statistical significance. The Mickelson study enrolled only a small number of 
black and white patients, and may not have had the power to detect a statistically significant 
difference.  
Combined Revascularization Rates 
 There were 4 studies (Gregory 1999; Palmeri 2005; Iribarren 2005; Ding 2003) that 
evaluated combined revascularization rates (PTCA and CABG) between black and white patients 
presenting with AMI. All 4 showed that white patients received revascularization procedures 
more often than black patients. The measured difference in each study achieved statistical 
significance.  
In-Hospital Mortality 
 In-hospital mortality was evaluated by six studies (Barnhart 2006; Maynard 1997; 
Maynard 1991; Taylor 1998; Palmeri 2005; Giles 1995) within the review. All 6 articles were 
rated poorly within this review on study group comparability, describing validity and reliability 
of measurements, identification and consideration of main confounders, and ability to minimize 
the risk of bias or confounding. All 6 studies did use regression models to control for those 
potential confounders measured, and did clearly define outcomes.  
A trend toward lower mortality among black patients was shown by 3 studies (Barnhart 
2006; Maynard 1991; Giles 1995), but this difference was not shown to be statistically 
significant in any of the studies. The Barnhart study consisted of 11,011 black and white patients 
with AMI, and produced a fairly narrow 95% CI (OR 0.83 95% CI 0.69-1.00) suggesting a 
reasonably precise estimate. The study had sufficient power to suggest a mortality difference 
between the groups, but was not strong enough to satisfy standards of statistical significance. The 
Maynard study (black mortality 7.4% vs. white mortality 13.1%, p = 0.07) consisted of 2,870 
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patients. The small study size and lack of reported confidence intervals decreases the 
interpretation of the power and precision of the study and its findings. The results of the Giles 
study showed a difference in mortality between black and white patients, but did not provide any 
means to interpret the statistical significance of this difference.  
There were 2 studies (Maynard 1997; Taylor 1998) that showed no mortality difference 
between groups. The Maynard study (OR 1.05 95% CI 0.72-1.54) consisted of 11,254 patients. 
The relatively wide 95% CI indicates a fairly imprecise odds ratio estimate. It is possible that the 
study did not have sufficient power to detect a difference between the groups. The Taylor study 
consisted of 275,046 patients. The study reported no statistical difference in hospital mortality 
between the groups within the text of the results, but did not provide actual numerical data to 
support or interpret these claims.  
There was 1 study (Palmeri 2005) that showed a trend toward higher mortality in blacks 
compared to whites, but the difference did not achieve statistical significance (OR 1.82 95% CI 
0.84-3.94). It should be noted that the Palmeri study focused on patients with cardiogenic shock 
complicating AMI, and therefore the study population and likely benefit from intervention differ 
for this study compared to the others in the review. The study consisted of 538 patients, and had 
sufficient power to suggest a mortality difference between the groups, but was not strong enough 
to satisfy standards of statistical significance. 
30-Day Mortality 
30-day mortality was evaluated by 2 studies (Ford 2000; Petersen 2002) in the review. 
Neither study showed a statistically significant difference between black and white patients for 
30-day mortality. The studies were rated poorly according to study group comparisons and 
describing validity and reliability of race/ethnicity and mortality measures. Both studies clearly 
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defined outcomes and used regression models to control for those potential confounders 
measured. The Petersen article was one of the stronger studies in the review, it was evaluated to 
have an adequate description of exposure measures, adequate identification and consideration of 
confounders, and received an intermediate “-/+” grade on ability to limit bias and confounding. 
The study consisted of 4,611 black and white patients. The 95% CI (OR 0.99 95% CI 0.74-1.3) 
suggests a moderately precise estimate that evenly straddles an odds ratio suggesting no 
difference in mortality. The Ford study consisted of 10,016 black and white patients. The 95% CI 
(OR 0.87 95% CI 0.59-1.27) suggests the study may not have been powered sufficiently to 
generate a precise estimate of difference between the groups.  
1-Year Mortality  
1-year mortality was evaluated by 3 studies (Conigliaro 2000; Petersen 2002; Gregory 
1999). All 3 studies were rated poorly according to study population comparison. There were 2 
studies (Petersen 2002; Gregory 1999) that adequately identified and considered main 
confounders and also received intermediate grades for ability to limit potential bias and 
confounding.  
 2 of the 3 studies (Petersen 2002; Gregory 1999) suggested a slight trend toward lower 
mortality rates among black patients. Both studies were among highest rated in the review for 
identifying main potential confounders and minimizing bias. The Petersen study (OR 0.86 95% 
CI 0.68-1.09) suggested a trend toward lower mortality among all black and white patients with 
AMI.  The Gregory study suggested a trend toward lower mortality among black and white 
patients under the age of 65 (RR 0.85 95% CI 0.66-1.09), but no real difference for patients over 
the age of 65 (RR 1.03 95% CI 0.89-1.19). 
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 The Conigliaro study reported a black mortality rate of 5.2% and a white mortality rate of 
7.4%, but no p-values or confidence intervals were included with the data to evaluate the 
significance of the data.  
2-Year Mortality  
 2-year mortality was evaluated by 1 study (Mickelson 1997). This study was graded 
poorly according to study group comparisons and the describing of validity and reliability of 
measures. The study was graded poorly on identification of confounders and ability to minimize 
bias and confounding. The study did clearly define outcomes, and used regression models to 
control for those potential confounders that were measured. No statistically significant difference 
was seen in 22-month mortality in the Mickelson study (black mortality 30.9% vs. white 
mortality 23.3%, p>0.05). The study consisted of 316 black and white patients, and may have 
been insufficiently powered to detect a real statistically significant difference.  
3- Year Mortality 
3-year mortality was evaluated by 2 studies (Petersen 2002; Ding 2003). Both studies 
were graded poorly according to study group comparisons and the describing of the validity and 
reliability of measures for interventions and mortality. The Ding study did use patient self-report 
to measure race. The Petersen study adequately addressed confounding and had some ability to 
limit bias and confounding. Neither study showed a statistically significant difference between 
black and white patients, though the Petersen study showed a slight trend toward lower mortality 
in blacks (OR 0.93 95% CI 0.76-1.15) and the Ding study suggested a higher mortality rate (OR 
1.31 95% CI 0.83-2.00). It should be noted that the 3-year mortality calculation in the Ding study 
did not control for patient comorbidities, and may suggest a larger difference due to group 
variation in comorbidity status.  
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5- Year Mortality  
5-year mortality was evaluated by 1 study (Conigliaro 2000). The study was graded 
poorly according to study group comparison, describing validity and reliability of race/ethnicity 
and intervention measurements, identification and consideration of potential confounders, and its 
ability to minimize bias and confounding. The study did adequately demonstrate a valid and 
reliable measure of mortality and used regression models to control for those potential 
confounders that were measured. The study results showed similar black and white mortality 
rates (23.3% vs. 26.2%), but no p-values or confidence intervals were included to evaluate the 
significance of the difference. 
Other Measures of Mortality 
The Iribarren 2005 study measured mortality according to age-adjusted mortality rate per 
100 person years. The study was graded poorly according to study group comparison, describing 
of validity and reliability of measures of interventions and mortality, and identification and 
consideration of potential confounders. The study was interpreted to have some ability to 
minimize the risk of bias, adequately addressed the validity and reliability of measures of race, 
clearly defined outcomes, and used regression models to control for measured confounders. The 
study showed that black men (HR 1.34 95% CI 1.18-1.52) and black women (HR 1.22 95% CI 
1.06-1.40) compared to white men had higher mortality rates. The difference in mortality rates 
achieved statistical significance for both comparisons. It should be noted that these calculations 
did not adjust for patient comorbidity, and that the observed difference may be partly due to 
variation between groups according to medical comorbidity.  
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Survival 
Survival was evaluated by 2 studies (Peterson 2002; Maynard 1997). The Peterson study 
was one of the stronger studies in the review. The study was evaluated to have adequate 
identification and consideration of confounders and received an intermediate grade of “-/+’ on 
ability to limit bias and confounding. The study showed that blacks had higher 30-day survival 
compared to whites (OR 1.18 95% CI 1.07-1.31), a difference that achieved statistical 
significance. The study showed a trend toward higher 1 year survival in black patients, but the 
difference narrowly missed achieving statistical significance (OR 1.07 95% CI 0.99-1.16). There 
was no statistical significant difference for 2 year survival (OR 1.01 95% CI 0.92-1.07).  
The Maynard study showed no statistically significant difference in 2 year survival 
between black and white patients (HR 0.93 95% CI 0.73-1.18).  This study was rated poorly as 
far as group comparability, reporting of the validity and reliability of key measurements, and the 
ability to limit potential confounders and bias. The study did clearly define measured outcomes 
and used regression models to control for measured confounders.  
 
Discussion 
This systematic review included 14 studies. The collection of evidence within this review 
strongly supports that black patients presenting with AMI receive both PTCA and CABG less 
often than white patients. This is finding is consistent with previously completed primary studies 
and reviews.
10-17, 19 
Despite this difference in procedure rates, the evidence collected in this 
review suggests that black patients have equal, and potentially lower, mortality rates after AMI 
compared to white patients.  
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Only 1 study (Iribarren 2005) reported that blacks suffered statistically significant higher 
mortality rates compared to whites. The Iribarren study did not provide a regression model that 
adjusted for medical comorbidity without controlling for revascularization procedures. A model 
controlling for age, insurance, and sociodemographic factors showed a statistically significant 
difference in mortality between blacks and whites. A second model adjusting for age, insurance, 
sociodemographic factors, comorbidities, and revascularization procedures showed no difference 
in mortality. Similarly, the Ding study showed a trend toward higher mortality in black patients, 
but did not control for medical comorbidities. From the provided models and results alone, it is 
not possible to discern if the mortality difference is primarily attributable to differences in 
comorbidity status or differences in revascularization rates.  
The Palmeri study showed a strong trend toward a racial difference in mortality (OR 1.82 
95% CI 0.84-3.94) that missed achieving statistical significance. The cohort for this study 
consisted of patients who all experienced AMI complicated by cardiogenic shock. Previous 
studies have shown that urgent revascularization for AMI complicated by shock can increase 1-
year survival by 14.1% (95% CI 2.9%-25.2%; P<.02). 
23 
Considering this added survival benefit, 
it is possible that racial differences in revascularization procedures lead to differences in 
mortality in the presence cardiogenic shock, but not for patients with uncomplicated AMI.  
 The overwhelming majority of the evidence in this review indicates that black patients 
have lower or equal mortality rates compared to white patients after AMI despite lower rates of 
revascularization procedures. This conclusion is surprising given the evidence that exists to 
support the mortality benefits of revascularization procedures post-AMI. The following is a 
discussion of 3 separate factors that may contribute to the paradoxical conclusion of this review.  
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Do the studies within this review use specialized patient populations not representative of 
national trends? 
4 of the studies included in this review used data made available through Veteran Affairs 
medical registries. VA specific medical data may differ from more general national sources due 
to a more homogenous patient base with fewer limitations on health care access, and may 
suggest mortality trends not representative of more national trends. 10 studies included in this 
review sampled patients from national, state, county, city, or hospital registries. The conclusions 
from the VA studies did not differ from the studies using these other data sources. Based on 
these findings, it does not appear that the use of specialized patient populations contributed to the 
review conclusion that there is no difference in black and white patient mortality after AMI 
despite differences in procedure use.   
Do differences exist in revascularization procedure efficacy based on patient race? 
 A difference in the efficacy of revascularization procedures between racial groups could 
theoretically explain the mortality paradox. If revascularization procedures were more effective 
in preventing mortality when performed on black AMI patients, a smaller number of procedures 
within this population could produce similar mortality benefits compared to a larger number of 
less efficacious procedures performed on white patients. This theory would require that blacks be 
either biologically more favorable to revascularization, or that they receive higher quality 
procedures. No evidence exists that supports either claim. Several studies have shown that blacks 
and whites have similar short term mortality outcomes after PCI,
24-29 
though some evidence 
suggests higher black mortality at 1-year
25 
and 2-years.
26 
Many studies have also looked at racial 
differences in post-operative CABG outcomes, and have shown that blacks compared to whites 
have similar
30-32 
or lower survival rates after CABG.
33-35 
Concerning the possibility that blacks 
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receive higher quality procedures, there is a significant amount of evidence throughout the 
literature that blacks and other minorities have less health care access, and overall receive lower 
standards of care compared to white patients. Based on the extensive minority associated 
inequalities present within healthcare, it is very unlikely that black patients are receiving higher 
quality revascularization procedures and that these differences account for the paradoxical 
conclusion of this review.  
Do more black patients with severe infarctions die before arriving at the hospital compared to 
white patients? 
 If a higher proportion of black patients with more severe infarctions died before hospital 
admission, the proportion of black patients with less severe infarctions would be greater than that 
of white patients.
36 
Studies have shown that blacks have higher rates of out of hospital infarction 
deaths,
37 
higher incidence of out of hospital cardiac arrest with lower rates of survival,
38 
and 
longer pre-hospital delay times compared to whites.
39 
These factors could potentially lead to a 
selection process producing a relatively healthier black AMI population with a baseline mortality 
rate that is lower than that of the less healthy white AMI population. In this scenario, the higher 
rate of revascularization procedures in the white AMI population would lead to a greater 
mortality benefit for whites, and the less the healthy white AMI population could achieve an 
overall mortality rate similar to the healthier black AMI population. Under these conditions, the 
revascularization mortality paradox would no longer be paradoxical, in that those patients 
receiving higher rates of revascularization procedures are achieving greater mortality benefits 
consistent with the evidence that supports the use of revascularization procedures post-AMI. 
 This selection model appears promising as a potential explanation for the findings of this 
review. Further data must be collected evaluating racial differences in severity of AMI at 
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presentation along with racial differences in prehospital death secondary to infarction. If this 
model is correct in its assessment, the underuse of revascularization procedures in black AMI 
patients is leading to poorer mortality outcomes for this population, and therefore would be 
clearly classified as a healthcare disparity. The model also emphasizes the intricacies of 
evaluating the equality and equity of healthcare, in that it creates a scenario where a healthcare 
disparity may exist in the presence of equivalent outcomes. It reinforces the idea that the primary 
determinant of true healthcare equity is clinical need. 
Study Limitations 
The overall methodologic quality of the included studies was poor. All 14 studies were 
affected by potential selection bias and confounding. Black and white comparison groups 
differed according to several measured, and very likely unmeasured, patient and clinical 
variables. The ability to select black and white comparison groups in the United States that differ 
only according to an intervention seems to be very unlikely considering historic, cultural, 
socioeconomic, health behavior, disease prevalence, and access to care differences that exist 
across these 2 populations. The fact that 11 of the 14 studies included in this review were 
retrospective and used previously collected data complicates the ability to accurately measure 
and adjust for all potential differences.  
The reporting of validity and reliability for key measures including race, 
revascularization procedures, and mortality for studies within this review was poor. There were 2 
studies that adequately addressed measures for race (Iribarren 2005; Ding 2003). Only 1 study 
(Petersen 2002) adequately described measures of revascularization procedures. Measures for 
mortality were adequately described in 2 studies (Conigliaro 2000; Iribarren 2005). This lack of 
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reporting may partially be caused by the use of previously collected data sources within 
retrospective studies, of which validity and reliability information is not available.  
The reporting of the quality of race measures was also poor within the review. The 
classification, definitions, and terminology used for racial/ethnic identification are complex and 
are consistently changing. A 2007 systematic review evaluating race/ethnicity reporting in major 
medical journals over a four year period found a total of  13 terms reported to infer “black” and 
16 terms used to infer “white” patients.40 Within this same review, only 159 of 1,152 articles 
(14%) described how racial/ethnic categories were assigned and 10 out of 1,152 articles (<1%) 
included mixed race/ethnicity as a separated category. The rate of reporting race/ethnicity 
assignment from the Ma et al. review is consistent with that found in my review (2 of 14 articles 
or 14%).   
The use of older data based on previous classification schemes further complicates the 
ability to accurately and reliably identify race; and may in theory alter the generalizability of 
racial outcomes of previous older primary studies to current defined racial groups. Only 2 studies 
within this review (Iribarren 2005; Ding 2003) incorporated self report of racial identification, 
which currently serves as the “gold standard” measure for race.41, 42  
The generalizability of the majority of the individual studies within this review is limited. 
Only 4 studies included a national sample of AMI patients (Peterson 1994; Petersen 2002; Giles 
1995; Taylor 1998). The remaining 10 studies were limited to single medical centers, cities, 
counties or states. Patient populations from these limited areas may not reflect national trends in 
disease prevalence and severity, quality of medical care, socioeconomic systems, racial/ethnic 
composition, and race/ethnicity associated empowerment and social power structures. Of the 4 
studies including a national sample, 2 studies (Peterson 1994; Petersen 2002) had populations 
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consisting of only men. Differences in revascularization and mortality between white men and 
black men have been shown to differ from differences observed between white men and black 
women.
43 
The findings of these studies may not be generalizable to black women. 
A majority of the studies included in the review suffered from poor methodological 
quality and reporting, and future studies are needed to clarify the effects a well documented 
racial difference in revascularization procedures has on patient outcomes after AMI. The fact that 
differences in procedure suggested a difference in mortality between black and white patients 
presenting with AMI complicated by cardiogenic shock suggests that there are clinical situations 
where this racial difference in care does negatively affect outcomes. Further research must work 
to identify similar clinical presentations and situations that may lead to differences in mortality. 
Research must also be conducted to examine potential differences in other health outcomes 
associated with AMI and treatment including recurrent infarction, stroke, functional status, and 
quality of life. It is possible that a difference in treatment does not affect mortality, but does 
create differences in these other important outcomes.  
To avoid the limitations of the previous studies included in this review, strong 
consideration should be taken to developing prospective studies of national samples to avoid the 
measurement, reporting, and generalizability limitations associated with using older regional 
data. The studies should be sufficiently powered to detect true difference if they exist. A 
systematic search for all potential confounders should be performed, and these variables should 
be measured and adjusted for to help limit the potential confounding created by the necessary 
comparison of racial/ethnic groups. Appropriate group measures should include socioeconomic 
indicators, medical comorbidity status, indicators of disease severity, and admission hospital 
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characteristics and treatment capabilities. Race should be measured by self-report, and valid and 
reliable measures of revascularization procedures and mortality should be used and reported.  
Review Limitations 
There are several limitations to this review. Articles were selected and analyzed by a 
single reviewer, creating the potential for both selection and measurement bias. Several steps 
were taken to help limit this potential for bias. Selection criteria were precisely defined and 
discussed with an experienced researcher before article selection. The electronic search was 
carried out with the direct assistance of a research specialist. Efforts were taken to explicitly 
describe the selection and review process, including detailed reference lists of excluded articles 
with reasons for exclusion and full length article reviews of included studies made available in 
the appendix section of this review. The use of MEDLINE as a primary source for this review 
creates a potential for publication bias. Studies published in “major” English medical journals 
may have been disproportionately represented. The use of alternative electronic databases and 
extensive hand searching may have helped limit publication bias, however, the limited research 
support for this review did not make this extended search strategy possible.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 28 
REFERENCES 
1. American Heart Association, American Stroke Association. Heart disease and stroke statistics. 
Available at: 
http://www.americanheart.org/downloadable/heart/1166711577754HS_StatsInsideText.pdf. 
Accessed June 28, 2007. 
2. Lilly L, ed. Pathophysiology of Heart Disease: A Collaborative Project of Medical Students 
and Faculty. 3rd ed. Lippincott Williams & Wilkins, US; 2002. 
3. Antman EM, Anbe DT, Armstrong PW, et al. ACC/AHA guidelines for the management of 
patients with ST-elevation myocardial infarction--executive summary. A report of the american 
college of Cardiology/American heart association task force on practice guidelines (writing 
committee to revise the 1999 guidelines for the management of patients with acute myocardial 
infarction). J Am Coll Cardiol. 2004;44:671-719. 
4. Myers WO, Davis K, Foster ED, Maynard C, Kaiser GC. Surgical survival in the coronary 
artery surgery study (CASS) registry. Ann Thorac Surg. 1985;40:245-260. 
5. Parisi A, Folland E, Hartigan P. A comparison of angioplasty with medical therapy in the 
treatment of single-vessel coronary artery disease. N Engl J Med. 1992;326:10-16. 
6. Yusuf S, Zucker D, Peduzzi P. Effect of coronary artery bypass graft surgery on survival: 
Overview of 10-year results from randomized trials by the coronary artery bypass graft surgery 
trialists collaboration. Lancet. 1994;344:563-570. 
 29 
7. Keeley E, Boura J, Grines C. Primary angioplasty versus intravenous thrombolytic therapy for 
acute myocardial infarction: A quantitative review of 23 randomized trials. Lancet. 2003;361:13-
20. 
8. Eagle K, Guyton R, Davidoff R, et al. ACC/AHA 2004 guideline update for coronary artery 
bypass graft surgery. Circulation. 2004;110:340-437. 
9. Antman EM, Anbe DT, Armstrong PW, et al. ACC/AHA guidelines for the management of 
patients with ST-elevation myocardial infarction--executive summary. A report of the american 
college of Cardiology/American heart association task force on practice guidelines (writing 
committee to revise the 1999 guidelines for the management of patients with acute myocardial 
infarction). J Am Coll Cardiol. 2004;44:671-719. 
10. Peterson E, Wright S, Daley J, Thibault G. Racial variation in cardiac procedure use and 
survival following acute myocardial infarction in the department of veterans affairs. JAMA. 
1994;271:1175-1180. 
11. Udvarhelyi S, Gastonis C, Epstein A, et. al. Acute myocardial infarction in the medicare 
population. JAMA. 1992;268:2530-2536. 
12. Taylor H, Canto J, Sanderson B, et. al. Management and outcomes for black patients with 
acute myocardial infarction in the reperfusion era. Am J Cardiol. 1998;82:1019-1023. 
13. Giles W, Anda R, Casper M, et. al. Race and sex differences in rates of invasive cardiac 
procedures in US hospitals. Archives of Internal Medicine. 1995;155:318-324. 
 30 
14. Maynard C, Litwin P, Martin J, et. al. Characteristics of black patients admitted to coronary 
care units in metropolitan seattle: Results from the myocardial infarction triage and intervention 
registry. Am J Cardiol. 1991;67:18-23. 
15. Maynard C, Every N, Martin J, et. al. Long-term implications of racial differences in the use 
of revascularization procedures (the myocardial infarction triage and intervention registry). Am 
Heart J. 1997;134:656-662. 
16. Maynard C, Sun H, Lowy E, et. al. The use of percutaneous coronary intervention in black 
and white veterans with acute myocardial infarction. BMJ Health Serv Research. 2006;6:107-
107. 
17. Weitzman S, Cooper L, Chambless L, et. al. Gender, racial, and geographic differences in the 
performance of cardiac diagnostic and therapeutic procedures for hospitalized acute myocardial 
infarction in four states. Am J Cardiol. 1997;6:722-726. 
18. Okelo S, Taylor A, Wright J, et. al. Race and the decision to refer for coronary 
revascularization. J Am Coll Cardiol. 2001;38:698-704. 
19. Kressin N, Petersen L. Racial differences in the use of invasive cardiovascular procedures: 
Review of the literature and prescription for future research. Ann Intern Med. 2001;135:352-366. 
20. Rathore S, Krumholz H. Differences, disparities, and biases: Clarifying racial variations in 
health care use. Ann Intern Med. 2004;141:635-638. 
21. Chang W. The meaning and goals of equity in health. J Epidemiol Community Health. 
;56:488-491. 
 31 
22. Agency for Healthcare Research and Quality. Systems to rate the strength of scientific 
evidence. Available at: http://www.ahrq.gov/clinic/epcsums/strengthsum.pdf. Accessed June 15, 
2007. 
23. Hochman J, Sleeper L, White H, et. al. One-year survival following early revascularization 
for cardiogenic shock complicating acute myocardial infarction. JAMA. 2001;285:190-192. 
24. Chen MS, Bhatt DL, Chew DP, et al. Outcomes in african americans and whites after 
percutaneous coronary intervention. The American Journal of Medicine. 2005;118:1019-1025. 
25. Leborgne L, Cheneau E, Wolfram R, et al. Comparison of baseline characteristics and one-
year outcomes between african-americans and caucasians undergoing percutaneous coronary 
intervention. Am J Cardiol. 2004;93:389-393. 
26. Slater J, Selzer F, Dorbala S, et al. Ethnic differences in the presenation, treatment strategy, 
and outcomes of percutaneous coronary intervention (A report from the national heart, lung, and 
blood institute dynamic registry). American Journal of Cardiology. 2003;92:773-778. 
27. Maynard C, Wright S, Every N, et al. Racial differences in outcomes of veterans undergoing 
percutaneous coronary interventions. American Heart Journal. 2001;142:309-313. 
28. Marks DS, Mensah G, Kennard E, et al. Race, baseline characteristics, and clinical outcomes 
after coronary intervention: The new approaches in coronary interventions (NACI) registry. 
American Heart Journal. 2000;140:162-169. 
 32 
29. Iqbal U, Pinnow E, Lindsay J. Comparison of six-month outcomes after percutaneous 
coronar intervention for whites versus african-americans. The American Journal of Cardiology. 
2001;88:304-305. 
30. Higgins R, Paone G, Borzak S, et al. Effect of payer status on outcomes of coronary artery 
bypass surgery in blacks. Circulation. 1998;98:Suppl:II46-II49. 
31. Maynard C, Ritchie J. Racial differences in outcomes of veterans undergoing coronary artery 
bypass grafting. American Journal of Cardiology. 2001;88:893-895. 
32. Peterson E, Wright S, Daley J, Thibault G. Racial variation in cardiac procedure use and 
survival following acute myocardial infarction in the department of veterans affairs. JAMA. 
1994;271:1175-1180. 
33. Brooks M, Jones R, Bach R, et al. Predictors of mortality and mortality from cardiac causes 
in the bypass angioplasty revascularization investigation (BARI) randmoized trial and registry. 
Circulation. 2000:2682-2689. 
34. Hartz R, Rao A, Plomondon M, Matloff J. Effects of ethnicity,with or without gender, on 
operative mortality after coronary artery bypass grafting: A study using the society of thoracic 
national database. . 2001;71:512-520. 
35. Bridges C, Edwards F, Peterson E, Coombs L. The effect of ethnicity on coronary bypass 
operative mortality. Journal of the American College of Cardiology. 2000;36:1870-1876. 
 33 
36. Roig E, Castaner A, Simmons B, et al. In-hospital mortality rates from acute myocardial 
infarction by race in the US hospitals: Findings from the national hospital discharge survey. 
Circulation. 1987;76:280-288. 
37. Keil J, Saunders D, Lackland D, et al. Acute myocardial infarction: Period prevalence, case 
fatality, and comparison of black and white cases in urban and rural areas of south carolina. 
American Heart Journal. 1985;109:776-784. 
38. Becker L, Han B, Meyer P, et al. Racial differences in the incidence of cardiac arrest and 
subsequent survival. N.Engl.J.Med. 1993;329:600-606. 
39. McGinn A, Rosamond W, Goff D, et al. Trends in prehospital delay time and use of 
emergency medical services for acute myocardial infarction: Experience in 4 US communinities 
from 1987-2000. American Heart Journal. 2005;150:392-400. 
40. Ma IW, Khan NA, Kang A, Zalunardo N, Palepu A. Systematic review identified suboptimal 
reporting and use of race/ethnicity in general medical journals. J Clin Epidemiol. 2007;60:572-
578. 
41. Kaufman JS. How inconsistencies in racial classification demystify the race construct in 
public health statistics. Epidemiology. 1999;10:101-103. 
42. Office of Management and Budget (US). Revisions to the standards for the classification of 
federal data on race and ethnicity. Fed Regist. ;62:58781-58790. 
43. Vaccarino V, Rathore S, Wenger N, et. al. Sex and racial differences in the management of 
acute myocardial infarction, 1994-2002. N Engl J Med. 2005;353:671-682. 
 34 
Appendix A: Catalog of Articles Excluded After Title and Abstract Review 
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percutaneous coronary intervention. The American Journal of Medicine. 2005; 118 (9): 1019-
1024 
- Cohort consisted of black and white patients who all received PCI. 
- Outcomes assessed were post-procedural only. 
 
2. Amano Y, Takayama M, Amano M, Kumazaki T. MRI of cardiac morphology and function 
after percutaneous transluminal septal myocardial ablation for hypertrophic obstructive 
cardiomyopathy. American Journal of Roentgenology. 2004 Feb; 182(2): 523-527. 
- Cohort consisted of patients treated for hypertrophic obstructive cardiomyopathy. 
- Intervention was the MRI imaging of cardiac structures post-PTCA septal myocardial 
ablation.  
- Outcomes assessed were MRI imaging findings only.  
 
3. Berger J, Sanborn T, Sherman W, Brown D. Comparison of three-year outcomes in blacks 
versus whites with coronary heart disease following percutaneous coronary intervention. The 
American Journal of Cardiology. 2004 Sep 1; 94(5): 647-649. 
 - Cohort consisted of black and white patients who all received PCI. 
 - Outcomes assessed were post-procedural only.  
 
4. Garg M, Vacek J, Hallas D. Coronary angioplasty in black and white patients: Demographic 
characteristics and outcomes. Southern Medical Journal. 2000 Dec; 93(12): 1187-1191. 
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 - Cohort consisted of black and white patients who all received PCI. 
 - Outcomes assessed were demographic and post-procedural only. 
 
5. Hassani S, Chu W, Wolfram R, et al. Clinical outcomes after percutaneous coronary 
intervention with drug-eluting stents in dialysis patients. The Journal of Invasive Cardiology. 
2006 Jun; 18(6): 273-277.  
 - Cohort consisted of patients who all received PCI. 
 - Outcomes assessed were post-procedural only.  
 
6. Jaar B, Astor B, Berns J, Powe N. Predictors of amputation and survival following lower 
extremity revascularization in hemodialysis patients. Kidney International. 2004 Feb; 65(2): 613-
620. 
 - Cohort consisted of ESRD patients with PVD. 
 - Intervention of interest was lower extremity revascularization. 
 - Outcomes based on lower extremity procedure only.  
 
7. Marks D, Mensah G, Kennard E, et al. Race, baseline characteristics, and clinical outcomes 
after coronary intervention: The New Approaches in Coronary Interventions (NACI) registry. 
American Heart Journal. 2000 Jul; 140(1): 162-169. 
- Cohort consisted of black and white patients who all received PCI. 
 - Outcomes assessed were demographic and post-procedural only.  
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8. Mastoor M, Iqbal U, Pinnnow E, Lindsay J. Ethnicity does not affect outcomes of coronary 
angioplasty. Clinical Cardiology. 2000 May; 23(5): 379-382. 
 - Cohort consisted of patients who all received PCI. 
 - Outcomes assessed were demographic and post-procedural only.  
 
9. Picano E, Bolognese L, Pirelli S, et al. Dipyridamole-echocardiography: Clinical usefulness 
following interventions. Echocardiography. 1992 Mar; 9(2): 219-223.  
 - Intervention was not coronary revascularization procedures  
 
10. Poludasu S, Cavusoglu E, Clark L, Marmur J. Impact of gender on in-hospital percutaneous 
coronary interventional outcomes in African-Americans. Journal of Invasive Cardiology. 2007 
Mar; 19(3): 123-128.  
 - Cohort consisted of black men and women who all received PCI.  
 - Outcomes assessed were demographic and post-procedural only. 
 
11. Ramaswami G, Tegos T, Nicolaides A, et al. Ultrasonic plaque character and outcome after 
lower limb angioplasty. Journal of Vascular Surgery. 1999 Jan; 29(1): 110. 
 - Cohort consisted of patients with PVD.  
 - Intervention of interest was lower limb angioplasty 
 - Outcomes assessed were related to lower limb angioplasty only. 
 
12. Scott N, Kelsey S, Detre K, et al. Percutaneous transluminal coronary angioplasty in African-
American patients (the National Heart, Lung, and Blood Institute 1985-1986 Percutaneous 
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Transluminal Coronary Angioplasty Registry). The American Journal of Cardiology. 1994 Jun 
15; 73(16): 1141-1146. 
 - Cohort consisted of black and white patients who all received PCI. 
 - Outcomes assessed were demographic and post-procedural only. 
  
13. Slater J, Selzer F, Dorbala S, et al. Ethnic differences in the presentation, treatment strategy, 
and outcomes of percutaneous coronary intervention (a report from the National Heart, Lung, 
and Blood Institute Dynamic Registry). The American Journal of Cardiology. 2003 Oct 1; 92(7): 
773-778. 
 - Cohort consisted of patients who all received PCI 
 - Outcomes assessed were demographic or post-procedural only.  
 
14. Smith L, Milano C, Molter B, et al. Preoperative determinants of postoperative costs 
associated with coronary artery bypass graft surgery. Circulation. 1994 Nov; 90(5): II124. 
 - Cohort consisted of patients who all received CABG.  
 - Outcomes assessed were demographic, cost and post-procedural related only.  
 
15. Sterling R, Graeber G, Albus R, et al. Results of myocardial revascularization in black males. 
American Heart Journal. 1984 Sep; 108(3 pt 2): 695-699. 
 - Cohort consisted of patients who all received CABG. 
 - Outcomes assessed were demographic and post-procedural only 
 - Study was published before 1990. 
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16. Trivedi A, Sequist T, Ayanian J. Impact of hospital volume of racial disparities in 
cardiovascular procedure mortality.  
- Cohort consisted of patients who all received either CABG, PTCA, AAA, and CEA. 
- Outcomes assessed were demographic and post-procedural only.  
 
17. Becker E, Rahimi A. Disparities in race/ethnicity and gender in in-hospital mortality rates for 
coronary artery bypass surgery patients. Journal of National Medical Association. 2006 Nov; 
98(11): 1729-1739. 
 - Cohort consisted of patients who all received CABG. 
 - Outcomes assessed were demographic and post-procedural only.  
 
18. Boscarino J, Chang J. Survival after coronary artery bypass graft surgery and community 
socioeconomic status: Clinic and research implications. Medical Care. 1999 Feb; 37(2): 210-216. 
 - Cohort consisted of patients who all received CABG. 
 - Outcomes assessed were demographic and post-procedural only. 
 
19. Bridges C, Edwards F, Peterson E, Coombs L. The effect of race on coronary bypass 
operative mortality. Journal of the American College of Cardiology. 2000 Nov 15; 36(6): 1870-
1876. 
 - Cohort consisted of patients who all received CABG. 
 - Outcomes assessed were demographic and post-procedural only. 
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20. Gray R, Nessim S, Khan S, et al. Adverse 5-year outcome after coronary artery bypass 
surgery in blacks. Archives of Internal Medicine. 1996 Apr 8; 156(7): 769-773. 
 - Cohort consisted of patients who all received CABG. 
 - Outcomes assessed were demographic and post-procedural only. 
 
21. Hartz H, Rao A, Plomondon M, et al. Effects of race, with or without gender, on operative 
mortality after coronary artery bypass grafting: A study using The Society of Thoracic Surgeons 
National Database. The Annals of Thoracic Surgery. 2001 Feb; 71(2): 512-520. 
 - Cohort consisted of patients who all received CABG. 
 - Outcomes assessed were demographic and post-procedural only. 
 
22. Higgins R, Paone G, Borzak G, et al. Effect of payer status on outcomes of coronary artery 
bypass surgery in blacks. Circulation. 1998 Nov 10; 98(19 suppl): II46. 
 - Cohort consisted of patients who all received CABG. 
 - Outcomes assessed were demographic and post-procedural only. 
23. Konety S, Vaughan-Sarrazin M, Rosenthal G. Patient and hospital differences underlying 
racial variation in outcomes after coronary artery bypass graft surgery. Circulation. 2005 Mar 15; 
111(10): 1210-1216. 
  - Cohort consisted of patients who all received CABG. 
- Outcomes assessed were patient demographics, hospital demographics and post-
procedural only. 
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24. Kutner N, Zhang R, Huang Y, Herzog C. Cardiac rehabilitation and survival of dialysis 
patients  after coronary bypass. Journal of the American Society of Nephrology. 2006 Apr; 
17(4): 1175-1180. 
 - Cohort consisted of dialysis patients who all received CABG. 
 - Outcomes assessed were demographic and post-procedural only. 
 
25. Lucas F, Stukel T, Morris A, et al. Race and surgical mortality in the United States. Annals 
of Surgery. 2006 Feb; 243(2): 281-286.  
- Cohort consisted of patients who received 1 of 8 cardiovascular and cancer procedures. 
- Outcomes assessed were demographic and post-procedural only.  
 
26. Mandal A, Kaushik V, Oparah S. Risk of aortocoronary bypass surgery in a low-volume 
inner city hospital. Journal of the National Medical Association. 1991 Jun; 83(6): 519-521. 
 - Cohort consisted of patients who all received CABG. 
 - Outcomes assessed were demographic and post-procedural only. 
 
27. Maynard C, Fisher L, Passamani E. Survival of black persons compared with white persons 
in the Coronary Artery Surgery Study (CASS). The American Journal of Cardiology. 1987 Sep 
1; 60(7): 513-518. 
 - Study published before 1990.  
 - Data collected from years 1974-1979.  
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28. Michael Smith  J, Soneson E, Woods S, et al. Coronary artery bypass graft surgery outcomes 
among African-Americans and Caucasian patients. International Journal of Surgery. 2006; 4(4): 
212-216.  
 - Cohort consisted of patients who all received CABG.  
 - Outcomes assessed were demographic and post-procedural only. 
 - Study design was a nested case-control study. 
 
29. Mukamel D, Murthy A, Weimer D. Racial differences in access to high-quality cardiac 
surgeons. American Journal of Public Health. 2000 Nov; 90(11): 1174-1177. 
 - Cohort consisted of patients who all received CABG. 
- Outcomes assessed were demographic, procedural referral patterns post-procedural 
only. 
 
30. Nallamothu B, Saint S, Saha S, et al. Coronary artery bypass grafting in Native Americans: A 
higher risk of death compared to other ethnic groups? Journal of General Internal Medicine. 
2001 Aug; 16(8): 554-559. 
 - Cohort consisted of patients who all received CABG. 
 - Outcomes assessed were demographic and post-procedural only. 
 
31. Oberman A, Cutter G. Issues in the natural history and treatment of coronary heart disease in 
black populations: Sugrical treatment. American Heart Journal. 1984 Sep; 108(3 pt 2): 688-694. 
 - Cohort consisted of patients who all received CABG. 
 - Outcomes assessed were demographic and post-procedural only. 
 42 
 - Study was published before 1990. 
 - Data collected from 1970-1978. 
 
32. Rothenberg B, Pearson T, Zwanziger J, Mukamel D. Explaining disparities in access to high-
quality cardiac  surgeons. The Annals of  Thoracic Surgery. 2004 Jul; 78(1):  
1-18. 
 - Cohort consisted of patients who all received CABG. 
- Outcomes assessed were demographic and surgical quality measures only.  
 
33. Rumsfeld J, Plomondon M, Peterson E. The impact of ethnicity on outcomes following 
coronary artery bypass graft surgery in the Veterans Affairs Health Administration. Journal of 
the American College of Cardiology. 2002 Nov20; 40(10): 1786-1793. 
 - Cohort consisted of patients who all received CABG. 
 - Outcomes assessed were demographic and post-procedural only. 
 
34. Siddique R, Siddique M, Connors A, Rimm A. Thirty-day case-fatality rates for pulmonary 
embolism in the elderly. Archives of Internal Medicine. 1996 Nov 11; 156(20): 2343-2347. 
 - Cohort consisted of patients with pulmonary embolism. 
 - Outcomes assessed were based on the diagnosis of pulmonary embolism.  
 
35. Simmons B, Castaner A, Santhanam V, et al. Outcome of coronary artery bypass grafting in 
black persons. The American Journal of Cardiology. 1987 Mar 1; 59(6): 547-551.  
 - Cohort consisted of patients who all received CABG. 
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 - Cohort consisted of black patients only, no white comparison group. 
 - Outcomes assessed were demographic and post-procedural only. 
 
36. Taylor N, O’Brien S, Edwards F, et al. Relationship between race and mortality and 
morbidity after valve replacement surgery. Circulation. 2005 Mar 15; 111(10): 1305-1312.  
 - Cohort consisted of patients receiving mitral valve or aortic valve replacement.  
 - Outcomes assessed based on valve replacement surgery only.  
 
37. Williams J, Karp R, Kirklin J, et al. Considerations in selection and management of patients 
undergoing valve replacement with glutaraldehyde-fixed porcine bioprotheses. The Annals of 
Thoracic Surgery. 1980 Sep; 30(3): 247-258. 
- Cohort consisted of patients receiving aortic, mitral, or aortic plus mitral valve 
replacement. 
- Outcomes assessed based on valve replacement surgery only. 
- Study published before 1990. 
- Data collected between 1973-1978. 
 
38. Woods S, Noble G, Smith J, Hasselfield K. The influence of gender in patients undergoing 
coronary artery bypass graft surgery: An eight-year prospective hospitalized  cohort study. 
Journal of the American College of Surgeons. 2003 Mar; 196(3): 428-434.  
 - Cohort consisted of patients who all received CABG. 
 - Outcomes assessed were demographic and post-procedural only. 
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39. Zacharias A, Schwann T, Riordan C, et al. Operative and late coronary artery bypass grafting 
outcomes in matched African-American versus Caucasian  patients: evidence of a late survival-
Medicaid association. 
 - Cohort consisted of patients who all received CABG. 
 - Outcomes assessed were demographic and post-procedural only. 
 
40. Cutter G, Oberman A, Kouchoukos N, Rogers W. Epidemiologic study of candidates for 
coronary artery bypass surgery. Circulation. 1982; 66 (5 pt 2): III6-15.  
 - Study published before 1990. 
 
41. Gillum R. Coronary artery bypass surgery and coronary angiography in the United States, 
1979-1993. American Heart Journal. 1987; 113(5): 1255-1260. 
 - Study published before 1990. 
 
42. Gillum R, Feinleib M. Coronary heart disease in the elderly. Comprehensive Therapy. 1988; 
14(8): 66-73. 
 - Study published before 1990. 
 
43. Watkins L, Gardner K, Gott V, Gardner T. Coronary heart disease and bypass surgery in 
urban blacks. Journal of the National Medical Association. 1983; 75(4): 381-383.  
 - Study published before 1990. 
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44. Mukamel D, Weimer D, Mushlin A. Referrals to high-quality cardiac surgeons: Patients’ 
race and characteristics of their physicians. Health Services Research. 2006; 41: 1276-1295. 
 - Cohort consisted of patients who all received CABG.  
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Appendix B: Catalog of Articles Excluded After Full Text Review 
 
1. Bradley E, Herrin J, Wang Y, et al. Racial and ethnic differences in time to acute reperfusion 
therapy for patients hospitalized with myocardial infarction. JAMA. 2004; 292(13): 1563-1572.  
- Outcome assessed is time to treatment only.  
 
2. Sharis P, Cannon C, Rogers W, et al. Predictors of mortality, coronary angiography, and 
revascularization in unstable angina pectoris and acute non-ST elevation myocardial infarction 
(the TIMI III Registry). The American Journal of Cardiology. 2002 Nov 15; 90(10): 1154-1156. 
 - Cohort consists of only unstable angina and NSTEMI patients only. 
- Outcomes assessed are based only on unstable angina or NSTEMI diagnoses. 
 
3. Kelly R, Hashim A, Al-Dallow R. Recommendations and performance of coronary 
revascularization procedures in black and white patients. The American Journal of Cardiology. 
2005 Jul 15; 96(2): 215-217. 
- Outcomes assessed are procedural recommendation by race and procedure rates by race 
only.  
 
4. Philbin E, McCullough P, DiSalvo T, et al. Socioeconomic status is an important determinant 
of the use of invasive procedures after acute myocardial infarction in New York State. 
Circulation. 2000 Nov 7; 102(19 suppl 3): III107-15. 
- Outcomes assessed are compared based only by socioeconomic status. No comparisons 
are made between outcomes based on race.  
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5. Maynard C, Wright S, Every N, Ritchie J. Racial differences in outcomes of veterans 
undergoing percutaneous coronary interventions. American Heart Journal. 2001 Aug; 142(2): 
309-313. 
 - Cohort consisted of patients who all received PCI. 
- Outcomes assessed are post-procedural results only.  
 
6. McBean A, Warren J, Babish J. Continuing differences in the rates of percutaneous 
transluminal coronary angioplasty and coronary artery bypass surgery between elderly black and 
white Medicare beneficiaries. American Heart Journal. 1994 Feb; 127(2): 287-295.  
 - Outcomes assessing mortality are post-procedural only.  
 
7. Minutello R, Chou E, Hong M, Wong S. Impact of race and ethnicity on inhospital outcomes 
after percutaneous coronary intervention (report from the 2000-2001 New York State 
Angioplasty Registry). American Heart Journal. 2006 Jan; 151(1): 164-167. 
 - Cohort consisted of patients who all received PCI 
- Outcomes assessed are post-procedural results only.  
 
8. Brown A, Sease K, Robey J, et al. The impact of B-type natriuretic peptide in addition to 
troponin I, creatine kinase-MB, and myoglobin on the risk stratification of emergency 
department chest pain patients with potential acute coronary syndrome. Annals of Emergency 
Medicine. 2007 Feb; 49(2): 153-163. 
 - Intervention was the use of BNP as a marker for acute coronary syndrome. 
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- Outcomes assessed are the testing characteristics of BNP along with associated acute 
coronary syndrome outcomes.  
 
9. Gurm H, Lincoff A, Kleiman N, et al. Double jeopardy of renal insufficiency and anemia in 
patients undergoing coronary interventions. The American Journal of Cardiology. 2004 Jul 1; 
94(1): 30-34. 
 - Cohort consisted of patients who all received PCI. 
- Outcomes assessed are the effects of anemia and renal insufficiency in post-procedural 
outcomes. 
 
10. Peterson E, Shaw L, DeLong E, et al. Racial variation in the use of coronary-
revascularization procedures. Are the differences real? Do they matter? New England Journal of 
Medicine. 1997; 336: 480-486. 
- Cohort consisted of general ischemic heart disease patients including acute and chronic 
disease. 
- Outcomes assessed are revascularization rates and survival for all ischemic patients. No 
AMI specific outcome data is provided. 
 
11. Werner R, Asch D, Polsky D. Racial profiling: The unintended consequences of coronary 
artery bypass graft report cards. Circulation. 2005; 111: 1257-1263. 
- Outcomes assessed are racial differences in revascularization rates only. 
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12. Ferguson J, Tierney W, Westmoreland G, et al. Examination of racial differences in 
management of cardiovascular disease. Journal of the American College of Cardiology. 1997; 
30: 1707-1713. 
- Cohort consisted of patients with general cardiovascular disease, including acute and 
chronic disease. 
- Outcomes assessed are racial differences in procedure rates and survival based on a 
diagnoses of cardiovascular disease. No AMI specific outcome data is provided. 
 
13. Leborne L, Cheneau E, Wolfram R, et al. Comparison of baseline characteristics and one-
year outcomes between African-Americans and Caucasians undergoing percutaneous coronary 
intervention. American Journal of Cardiology. 2004; 93: 389-393.  
 - Cohort consisted of patients who all received PCI. 
- Outcomes assessed are post-procedural results only. 
 
14. Lubitz J, Gornick M, Mentnech R, Loop F. Rehospitalizations after coronary 
revascularization among Medicare beneficiaries. American Journal of Cardiology. 1993; 72: 26-
30.  
 - Cohort consisted of Medicare patients receiving either PTCA or CABG. 
- Outcomes assessed are post-procedural results only.  
 
15. Peniston R, Lu D, Papademetriou V, Fletcher R. Severity of coronary artery disease in black 
and white male veterans and likelihood of revascularization. American Heart Journal. 2000; 139: 
840-847. 
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- Cohort consisted of patients who received cardiac catheterization for varying forms of 
heart disease including acute and chronic presentations.  
- Outcomes assessed are race differences in procedural rates and mortality for heart 
disease patients as a whole. No AMI specific outcome data is provided.  
 
 
16. Kressin N, Glickman M, Peterson E, et al. Functional status outcomes among white and 
African-American cardiac patients in an equal access system. American Heart Journal. 2007; 
153: 418-425.  
- Cohort consisted of patients with coronary artery disease, including chronic and acute 
manifestations. 
- Main outcome assessed is functional status only. No mortality data is provided.  
 
 
17. Brown S. Effects of race on mortality and use of hospital services in Maryland, 1998. Journal 
of Health and Social Policy. 2004; 19(1): 77-89. 
- Cohort consisted  of patients that received 1 of 17 hospital procedures (cardiac and non-
cardiac procedures) 
- Outcomes assessed are racial differences in procedural rates and post-procedural 
mortality only. 
 
18. Gillum R, Mussolino M, Madans J. Coronary heart disease incidence and survival in African-
American women and men. Annals of Internal Medicine. 1997; 127: 111-118.  
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- Cohort consisted of general coronary heart disease patients (including chronic and acute 
disease.) 
- Outcomes assessed are racial differences in coronary heart disease incidence, procedure 
rates, and survival. No AMI specific outcome data is provided.  
 
19. Hravnak M, Ibrahim S, Kaufer A, et al. Racial disparities in outcomes following coronary 
artery bypass grafting. Journal of Cardiovascular Nursing. 2006; 21(5): 367-378. 
- Review of available literature on the contributory factors to differences in CABG use 
and post-procedural outcomes only.  
 
20. Maynard C, Ritchie J. Racial differences in outcomes of veterans undergoing coronary artery 
bypass grafting. The American Journal of Cardiology. 2001; 88: 893-895 
 - Cohort consisted of patients who all received CABG. 
 - Outcomes assessed are post-procedural results only.  
 
21. Manhapra A, Canto J, Barron H, et al. Underutilization of reperfusion therapy in elgible 
African Americans with acute myocardial infarction: Role of presentation and evaluation of 
characteristics. American Heart Journal. 2001; 142: 604-610. 
- Cohort consisted of black patients diagnosed AMI. There was no white comparison 
group included.  
- Outcomes assessed are primarily focused on disease presentation characteristics. No 
mortality data is provided. 
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22. Scott R. The challenges of  health disparity and cardiovascular outcomes. The Annals of 
Thoracic Surgery. 2001; 71: 405-406.  
 - Editorial article. Article is not a cohort study.  
 
23. Epstein A, Weissman J, Schneider E, et al. Race and gender disparities in rates of cardiac 
revascularization. Do they reflect appropriate use of procedures or problems in quality of care? 
Medical Care. 2003; 41: 1240-1255. 
- Cohort consisted of patients who underwent cardiac catheterization for suspected 
coronary disease (including UA, MI, angina, etc). 
- Outcomes assessed are primarily focused on the appropriateness of revascularization 
procedures of coronary disease patients. No specific AMI mortality data is provided. 
 
24. Williams M, Hill G, Jackson M. The impact of an acute myocardial infarction guideline and 
pathway on racial outcomes at a university hospital. Ethnicity and Disease. 2006; 16: 653-658.  
- Study assesses clinical treatment and outcomes after a hospital wide quality assurance 
program intervention.  
 
25. Brooks M, Jones R, Bach R, et al. Predictors of mortality and mortality and mortality from 
cardiac causes in the Bypass Angioplasty Revascularization Investigation (BARI) Randomized 
Trial and Registry. Circulation. 2000; 101: 2682-2689. 
 - Cohort consisted of patients who all received PTCA or CABG. 
 - Outcomes assessed are post-procedural results only. 
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26. Little-Blanton M, Maddox T, Rushing O, Mensah G. Disparities in cardiac care: Rising to the 
challenge of Healthy People 2010. Journal of American The American College of Cardiology. 
2004; 44: 503-508.  
- Review article discussing racial differences in procedural rates. No mortality outcome 
data is provided.  
 
27. Liao Y, Cooper R, Ghali J, Szocka A. Survival rates with coronary artery disease for black 
women compared with black men. JAMA.1992; 268: 1867-1871. 
- Cohort consists of all black patients with CAD. No white comparison group was 
included. 
- Outcome comparisons are based on sex only. There is no outcome data describing 
differences between black and white patients.  
 
28. Iqbal U, Pinnow E, Lindsay J. Comparison of six-month outcomes after percutaneous 
coronary intervention for whites versus African-Americans. The American Journal of 
Cardiology. 2001; 88: 304-305. 
 - Cohort consisted of patients who all received PCI. 
 - Outcomes assessed are post-procedural results only.  
 
29. Eggers P, Greenberg G. Racial and ethnic differences in hospitalization rates among aged 
Medicare beneficiaries, 1998. Health Care Financing Review. 2000; 21(4): 91-105. 
- Cohort consisted of ischemic heart disease patients (both acute and chronic forms) 
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- Outcomes assessed are racial differences in hospitalization rates, procedure rates, and 
mortality for ischemic heart disease patients. No specific AMI outcome data is provided.  
 
30. Dilmanian H, Aronow W, Das M, et al. In-hospital mortality and time from onset of 
symptoms of acute myocardial infarction in 540 patients undergoing primary coronary 
angioplasty. Cardiology. 2007; 107: 107-110.  
 - Cohort consisted of patients who all received PCI. 
 - Outcomes assessed are post-procedural results only. 
 
31. Glaser R, Herrmann H. PCI in African-American women: Closing the gender gap. The 
Journal of Invasive Cardiology. 2007; 19(3): 129-130. 
 - Non-observational study 
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Appendix C: Catalog of Selected Articles from Electronic Search 
 
1. Barnhart J, Fang J, Alderman M. Differential use of coronary revascularization and hospital 
mortality following acute myocardial infarction. Archives of Internal Medicine. 2003; 163: 461-
466. 
 
2. Ford E, Newman J, Newman J, Deosaransingh K. Racial and ethnic differences in the use of 
cardiovascular procedures: Findings from the California Cooperative Cardiovascular Project. 
American Journal of Public Health. 2000; 90: 1128-1134. 
 
3. Conigliaro J, Whittle J, Good C, et al. Archives of Internal Medicine. 2000; 160: 1329-1335. 
Understanding racial variation in the use of coronary revascularization procedures. Archives of 
Internal Medicine. 2000; 160: 1329-1335. 
 
4. Maynard C, Every N, Martin J, et al. Long-term implications of racial differences in the use of 
revascularization procedures (the Myocardial Infarction Triage and Intervention Registry). 
American Heart Journal. 1997; 134: 656-662. 
 
5. Maynard C, Litwin P, Martin J, et al. Characteristics of black patients admitted to coronary 
care units in Metropolitan Seattle: Results from the Myocardial Infarction Triage and 
Intervention Registry (MITI). American Journal of Cardiology. 1991; 67: 18-23.  
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6. Mickelson J, Blum C, Geraci J. Acute myocardial infarction: Clinical characteristics, 
management, and outcome in a metropolitan veterans affairs medical center teaching hospital. 
Journal of the American College of Cardiology. 1997; 29: 915-925.  
 
7. Petersen L, Wright S, Peterson E, Daley J. Impact of race on cardiac care and outcomes in 
veterans with acute myocardial infarction. Medical Care. 2002; 40: I86-I96. 
 
8. Taylor H, Canto J, Sanderson B, et al. Management and outcomes for black patients with 
acute myocardial infarction in the reperfusion era. American Journal of Cardiology. 1998; 82: 
1019-1023.  
 
9. Gregory P, Rhoads G, Wilson A, et al. Impact of availability of hospital-based invasive 
cardiac services on racial differences in the use of these services. American Heart Journal. 1999; 
138: 507-517. 
 
10. Palmeri S, Lowe A, Sleeper L, et al. Racial and ethnic differences in the treatment and 
outcome of cardiogenic shock following acute myocardial infarction. American Journal of 
Cardiology. 2005; 96: 1042-1049. 
 
11. Giles W, Anda R, Casper M, et al. Race and sex differences in rates of invasive cardiac 
procedures in US hospitals. Archives of Internal Medicine. 1995; 155: 318-324.  
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Catalog of Selected Articles Selected from Reference Lists 
 
1. Iribarren C, Tolstykh I, Somkin C, et al. Sex and racial/ethnic disparities in outcomes after 
acute myocardial infarction. A cohort study among members of a large integrated health care 
delivery system in northern California. Archives of Internal Medicine. 2005; 165: 2105-2113.  
 
2. Ding J, Diez Roux A, Nieto J, et al. Racial disparity in long-term mortality rate after 
hospitalization for myocardial infarction: The Atherosclerosis Risk in Communities study. 
American Heart Journal. 2003; 146: 459-464.  
 
3. Peterson E, Wright S, Daley J, Thibault G. Racial variation in cardiac procedure use and 
survival following acute myocardial infarction the Department of Veterans Affairs. JAMA. 
1994; 271(15): 1175-1180.  
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Appendix D: Complete Article Reviews 
 
1. Citation: Barnhart J, Fang J, Alderman  M. Differential use of coronary revascularization and 
hospital mortality following acute myocardial infarction. Archives of Internal Medicine. 2003; 
163: 461-465. 
Study Question: What is the association of coronary revascularization with hospital mortality in 
black, Hispanic, and white patients admitted to New York City hospitals with acute myocardial 
infarction? 
Research design: Retrospective cohort study 
Study population: Patients recorded in the New York State Department of Health Statewide 
Planning and Research Cooperate System (SPARCS) identified as black, white, or Hispanic who 
were 35 years and older and admitted to an NYC hospital with a principal discharge diagnosis of 
AMI in 1996. 
- 12555 patients were eligible and included in the study (9138 white, 1873 black, and 1544 
Hispanic) 
Identification of race/ethnicity: Based on demographic information obtained from medical 
records and coded to describe the ethnic origin of patients.  
Identification of AMI: International Classification of Diseases, Ninth revision, Clinical 
Modification chart codes for AMI. 
Initial comparability of groups: White patients compared to black patients were 6.1 years older 
(p<.001), more likely to be male (58.6% vs 49.6%, p<.001), and more likely to have some form 
of insurance (94.7% vs 88.5%, p = .02). Blacks were more likely to have statistically significant 
higher rates of HTN (62.9% vs 44.7%), DM (38.2% vs 25.9%), and high cholesterol (13.2% vs 
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12.1%).  Whites were more likely to have statistically higher rates of CHF (36.3% vs 29.1%) and 
shock (3.8% vs 2.3%) compared to blacks.  
Drop Outs / Loss to Follow Up: N/A 
Potential for selection bias: The black and white comparison groups had statistically significant 
differences in age, sex, insurance status, medical comorbidities, and complications. Attempts to 
account for these initial differences were made through multiple regression models during data 
analysis for these known differences. Differences in treatment facility characteristics and access 
were not measured, and it is possible that the comparison groups differed in access to quality 
care. Other potential unknown and unaccounted for differences also may exist between the 
groups that were not accounted for in the analysis.  
Measurement of intervention: International Classification of Diseases, Ninth revision, Clinical 
Modification chart codes for angioplasty and coronary artery bypass surgery.  
Measurement of outcomes: Measures of hospital mortality were based on discharge status 
(dead or alive). No other information regarding mortality measures is given.  
Potential for measurement bias: No information is provided regarding the validity and 
reliability of using the New York State Department of Health Statewide Planning and Research 
Cooperate System (SPARCS) as a primary source of medical data to measure race, patient 
demographic information, clinical variables, treatments, or mortality.   
Potential confounders: Potential confounders considered were patient age, sex, race/ethnicity, 
principal diagnoses, cardiovascular risk comorbidities (HTN, DM, hypercholesterolemia), and 
SES (indicated by type of insurance).  
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Potential for confounding: No systematic approach to the identification of potential 
confounders is described, though a number of factors are identified, described between 
comparison groups, and statistically adjusted for using stratification and regression. No 
information is provided regarding the validity and reliability of using the New York State 
Department of Health Statewide Planning and Research Cooperate System (SPARCS) for the 
measurement of potential confounders.   
Analysis: Bivariate analyses were used to characterize the study population and calculate 
frequencies of cardiac procedure use and mortality stratified by age, sex, and race. Race specific 
multiple logistic regression models were used to compute ORs and 95% CIs using hospital 
mortality as the outcome variable, while controlling for covariates found to be significant from 
bivariate analyses. Separate regression models were stratified according to revascularization 
status to compare adjusted odds of death for blacks compared to whites who did and did not 
undergo the procedure.  
Results: Whites were more likely than blacks to receive PTCA (15.8% vs 9.7%, p<.001) and 
CABG (9.6% vs 6.2%, p<.001). Regression modeling controlling for age, sex, insurance status, 
comorbidities, and angiography status also showed blacks were less likely to be revascularized 
than whites (OR 0.56 95% CI 0.48-0.66). Age adjusted mortality rates were higher in whites than 
blacks (6.4 per 100 vs 5.9 per 100 hospitalizations), though this difference was not statistically 
significant. Blacks had slightly lower hospital mortality than whites (OR 0.83 95% CI 0.69-1.00) 
after controlling for age, sex, insurance status, comorbid medical conditions, and complications, 
and revascularization status.  
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Overall judgment of internal validity: The internal validity of this study is threatened by the 
potential selection bias, measurement bias, and confounding described above. Validity would be 
strengthened by including a systematic search for potential confounders, more detailed group 
comparative information, and larger statistical models to control for more potential confounders. 
More information about the accuracy and completeness of the medical records system used 
would also strengthen internal validity.  
Overall judgment of external validity: The external validity of this study is threatened by the 
selection of patients only from New York City hospitals. Geographic differences in acute 
myocardial infarction severity and treatment may limit the generalizability of this study. The 
inclusion of patients from a broader sample of treatment areas would increase the external 
validity of the study.  
Overall conclusions/interpretations: The study results indicate that despite racial differences in 
rates of revascularization, in hospital-mortality rates remain similar between blacks and whites. 
The study results are limited by significant potential for selection bias, measurement bias, and 
confounding.  
 
2. Citation: Conigliaro J, Whittle J, Good C, et al. Understanding racial variation in the use of 
coronary revascularization procedures. Archives of Internal Medicine. 2000; 160: 1329-1335. 
Study Question: Do differences in clinical presentation, including comorbidity, operative risk, 
and coronary anatomy, explain the differences in the use of PTCA and CABG between black and 
white male patients admitted with AMI or unstable angina.  
Research design: Retrospective cohort study 
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Study population: Male patients age 30 and older admitted to 1 of 6 Veterans Affairs hospitals 
from 1989-1995 with acute myocardial infarction or unstable angina who underwent cardiac 
catheterization. 
- 3137 eligible patients, of which 535 were black 
- Of the 535 black patients, 414 (77%) medical records were available.  
- Medical records for a white patient were requested for a matched black patient based on age, 
admitting diagnosis, and medical center. When not available, the medical record of another white 
matched patient was requested. 
- Overall requested 710 medical records, for which 517 were available (73%).  
- Those who had revascularization during the preceding year (51% black excluded patients vs. 
63% white excluded patients), had a primary hospital diagnosis other than AMI or unstable 
angina (33% vs. 24%), had no cardiac catheterization performed (0% vs 2%), had a decision to 
revascularize before admission (14% vs. 8%), incomplete records (0% vs. 3%), and actual race 
other than black or white (2% vs. 1%) were excluded.  
- Final study included 666 veterans (326 black, 340 white). 
- 316 of the 666 patients were AMI patients (149 black, 167 white).  
Identification of race/ethnicity: Recorded via Veterans Health Administration Patient 
Treatment File.  
Identification of AMI: International Classification of Diseases, Ninth revision, Clinical 
Modification chart codes for AMI. Diagnosis was confirmed by a chart review according to 
patient presentation, cardiac enzymes, and EKG changes.  
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Initial comparability of groups: Blacks compared to whites with AMI were more likely to have 
HTN (73% vs. 47%, p <0.001), DM (29% vs. 17%, p <0.001), and to abuse alcohol (46% vs. 
36%, p = 0.02). Whites tended to have higher degrees of stenosis according catheterization than 
blacks (severe stenosis 31% vs. 28%, moderate stenosis 15% vs. 7%, mild stenosis 47% vs. 46%, 
and no disease 7% vs. 19%, p = 0.002). RAND appropriateness for procedure ratings showed no 
significant differences between blacks and whites.  
Drop Outs / Loss to Follow Up: N/A 
Potential for selection bias: Black and white patients were matched according to age, admitting 
diagnosis, and medical center. Comparison data showed that blacks were more likely to have 
HTN, DM and to abuse alcohol, and less likely to have significant coronary disease on 
angiography compared to whites. Logistic regression models were used to control for group 
differences. Significant potential for sampling bias exists due to the unavailability of 23% of 
black patient and 27% of white patient requested medical records. 
Measurement of intervention: Administrative data from the Veterans Health Administration 
was used to measure procedure use. 
Measurement of outcomes: Administrative data from the Veterans Health Administration was 
used to measure mortality.  
Potential for measurement bias: No information is provided on the validity and reliability of 
obtaining medical information from Veterans Health Administration Patient Treatment Files to 
measure patient and clinical variables. Chart reviewers were masked to patient identifiers and 
race. No information is given providing the validity and reliability of using these treatment files 
to identify race, and whether information reflects self-identified or assigned racial identity. The 
use of the Beneficiary Identification and Record Locator to measure mortality was shown to be 
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98% concordant with mortality measures using Medicare Health Insurance Skeletonized 
Writeoff Files.  
Potential confounders: Potential confounders included were age, degree of stenosis, ejection 
fraction, comorbidity, prior MI, HTN, COPD, DM, peripheral vascular disease, smoking status, 
and alcohol abuse.  
Potential for confounding: No systematic approach to the identification of potential 
confounders is described. White and black patients included in the study were initially matched 
for age, admitting diagnosis, and medical center. The use of the VA health system was intended 
to decrease socioeconomic and access to care differences between the groups. Blacks and whites 
did differ on severity of stenosis, HTN, diabetes, and alcohol use. No indicator of SES was 
included in the analysis, and it is possible that controlling for SES may alter some of the racial 
differences observed. Logistic regression models were used to control for group differences in 
the analysis.  
Analysis: Chi-square tests were used to assess univariate relations between race and degree of 
stenosis, RAND appropriateness scores, and revascularization procedures. Multivariate 
polychotomous logistic regression was used to assess the independent effect of race on CABG 
and PTCA rates after controlling for RAND scores. Kaplan-Meier methods with Breslow 
statistics were used to test univariate relations between race, revascularization procedures, 
appropriateness, necessity levels, and time to death.  
Results: Black patients were less likely than whites to undergo any form of revascularization 
(28% vs. 47%, p <0.001). This difference was maintained when considering only patients with 
angiographically demonstrated coronary disease (38% vs 54%, p < 0.001). Procedure specific 
analysis showed blacks were significantly less likely to receive PTCA (OR 0.48 95% CI 0.32-
 65 
0.70) and CABG (OR 0.38 95% CI  0.24-0.60). The difference in procedure rates were 
maintained when only considering patients with significant coronary stenosis defined as greater 
than 50% obstruction (PTCA OR 0.58 95% CI 0.42-0.81 and CABG OR 0.47 95% CI 0.30-
0.74). No difference was found in 1 year mortality (5.2% vs. 7.4%) and 5 year mortality (23.3% 
vs. 26.2%) between blacks and whites.  
Overall judgment of internal validity: The internal validity of the study findings is threatened 
by a significant potential for selection bias. A significant number of blacks and whites were 
initially eligible for the study, but were later excluded because medical files were unavailable. 
The lack of information regarding the validity and reliability of measurement tools creates 
potential for measurement bias that may limit internal validity.  
Overall judgment of external validity: The study used medical information from 6 VA medical 
centers (Birmingham, Ala; Milwaukee, Wis; New York, NY; Philadelphia, PA; Pittsburgh, PA; 
and Los Angeles, CA) across the country with varying racial compositions. The fact that all 
medical centers used were in major metropolitan areas and all had the capacity to perform 
CABG on site may limit the generalizability of the study.  
Overall conclusions/interpretations: The study shows that black patients were less likely to 
receive any form of revascularization procedures compared to white patients. Despite this 
difference, no significant difference was seen between the two groups regarding 1 year and 5 
year mortality. A strong potential for selection bias may limit the accuracy of the study findings.  
 
3. Citation: Ding J, Diez Roux A, Nieto J, et al. Racial disparity in long-term mortality rate after 
hospitalization for myocardial infarction: The Atherosclerosis Risk in Communities Study. 
American Heart Journal. 2003; 146: 459-464. 
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Study Question: What mechanisms create the racial disparity in mortality rate after myocardial 
infarction?  
Research design: Prospective cohort study 
Study population: Patients from 4 communities (Forsyth County, NC; Jackson, Miss; 
Minneapolis, Minn; Washington County, MD) age 45-64 years at initial recruitment diagnosed 
with AMI from the previous Atherosclerosis Risk in Communities (ARIC) cohort study.  
- 642 patients identified (471 white, 171 black) 
- In both Minneapolis and Washington County, all subjects were white.  
- All patients from Jackson were black. 
- In Forsyth County, there were 161 white and 17 black patients included.  
Identification of race/ethnicity: Patient self-report 
Identification of AMI: Measured using hospital discharge indexes, death certificates, or 
information elicited through follow up patient interviews. Hospital chart abstraction was carried 
out to identify International Classification of Diseases 9
th
 Revision Clinical Modification codes 
for primary or secondary diagnoses of AMI.  
Initial comparability of groups: Blacks compared to whites were less likely to be male (48.5% 
vs. 68.8%, p = 0.001), had higher baseline BMI values (29.6 vs. 27.8, = 0.001), had less cigarette 
years of smoking at baseline (345.2 vs. 555.0, p = 0.001), had higher HDL levels at baseline 
(47.8 vs. 42.0, p = 0.001), had higher rates of baseline HTN (67.2% vs. 37.0%, p = 0.001), 
higher rates of diabetes at baseline (31.7% vs. 19.6%, p 0.001), lower rates of high school 
graduation at baseline (46.8% vs. 70.2%, p = 0.001), lower baseline income (>16K/yr) (37.1% 
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vs. 81.4%), lower rates of abnormal cardiac enzymes (78.8% vs. 86.4%, p = 0.02), and fewer 
receiving cardiac procedures after MI (21.6% vs. 57.1%, p = 0.001).  
Drop Outs / Loss to Follow Up: None 
Potential for selection bias: Black and white patients had statistically significant differences for 
several measured variables. These differences were controlled for using Cox proportional hazard 
models during analysis. The fact that all patients from Minneapolis and Washington County were 
white, and all patients included in the study from Jackson were black introduces the potential for 
key geographic related differences between the groups. It confounds the ability to distinguish if 
measured differences are actually due to race or to geographical location. It also creates a 
difficult context to interpret measured SES indicators, education and income levels may have 
very different meanings depending upon the socioeconomic characteristics of the region being 
considered.  
Measurement of intervention: Information on revascularization procedures collected from 
hospital charts.  
Measurement of outcomes: Mortality was measured using hospital discharge indexes, death 
certificates, or information elicited through follow up patient interviews 
Potential for measurement bias: Clinical and patient information was collected through patient 
examination and interview. Race was measured according to self-report. Mortality was measured 
using several sources including discharge indexes, death certificates, or information elicited 
through follow up contact. No patients are reported to have been lost to follow up.  
Potential confounders: Several factors are accounted for and grouped into 4 main categories: 
vascular risk factors, socioeconomic position, severity of MI, and treatment.  
 68 
Potential for confounding: No systematic approach to the identification of potential 
confounders is described, though a number of factors are identified, described between 
comparison groups, and statistically adjusted for. Hospital variables were not directly measured 
or adjusted for. The use of comparison groups from nearly exclusive geographic regions 
increases the risk for confounding.  
Analysis: Cox proportional hazard models were constructed to control for significant variables 
to assess racial disparity in mortality. Unadjusted case fatality rates were calculated using the 
Kaplan-Meier method.  
Results: Blacks received revascularization after AMI less often than whites (26.1% vs. 57.1%, p 
= 0.001).Unadjusted 3-year mortality was higher in blacks than whites (21% vs. 14%). After 
adjusting for age and sex, blacks still had higher rates compared to whites (Relative Hazard 
(RH): 1.80 95% CI 1.24-2.61). Mortality rates after adjusting for vascular risk factors (1.29 95% 
CI 0.83-2.00), adjusting for socioeconomic factors (RH 1.31 95% CI 0.83-2.09), adjusting for 
severity of MI (RH 1.60 95% CI 1.05-2.45), or adjusting for treatment (RH 1.36 95% CI 0.92-
2.00) were still higher for blacks. The model controlling for all factors provided a mortality RH 
of 1.00 (95% CI 0.56-1.77) for blacks compared to whites.  
Overall judgment of internal validity: The potential for selection bias and confounding limit 
the internal validity of study findings.  
Overall judgment of external validity: External validity is severely limited due to the small 
sample size and the limited locations sampled for the study. The 4 areas sampled for the study 
are all very unique in terms of population demographics compared to the rest of the United 
States. The inclusion of patients from a broader sample of treatment areas would increase the 
external validity of the study. 
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Overall conclusions/interpretations: The study shows that black patients receive 
revascularization procedures less often than whites. Blacks have significantly higher mortality 
rates after AMI compared to whites, a difference that remains after independently adjusting for 
vascular risk factors, socioeconomic factors, severity of MI, and treatment. The difference in 
mortality did not exist after adjusting for all 4 variable categories together. Findings are limited 
by potential selection bias and confounding based on regional exclusivity of comparison groups.  
 
4. Citation: Ford E, Newman J, Newman J, Deosaransingh K. Racial and ethnic differences in 
the use of cardiovascular procedures: Findings from the California Cooperative Cardiovascular 
Project. American Journal of Public Health. 2000; 90: 1128-1134. 
Study Question: Do racial or ethnic differences in the use of invasive and several non-invasive 
procedures exist among elderly patients admitted for treatment of an acute myocardial infarction 
in California? 
Research design: Retrospective cohort study 
Study population: Patients recorded in the Cooperative Cardiovascular Project (CCP) database 
admitted to 1 of 383 non-federal acute-care California hospitals for treatment of an acute 
myocardial infarction in 1994-1995 who were identified as Medicare patients from the Medicare 
Provider Analysis and Review Record.  
- 10,705 patients were identified as having a confirmed AMI who were 65 and older and who 
were not transferred to another hospital. 
- Only white, black, and Hispanic patients were included in the analysis. 
- 9489 white, 527 black, and 689 Hispanic patients were included in the study.  
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Identification of race/ethnicity: Abstracted from medical records.  
Identification of AMI: International Classification of Diseases, Ninth revision, Clinical 
Modification chart codes for AMI. AMI diagnosis was confirmed by a chart review according to 
patient presentation, cardiac enzymes, and EKG changes.  
Initial comparability of groups:  
Patient characteristics: White patients compared to black patients were older (19.3% vs 
13.5% age 80-84; 18.9% vs 12.3% 85 and older, p = 0.001)and more likely to be male 
(53.8% vs. 43.8%, p = 0.001). Blacks had higher rates of diabetes (40.2% vs. 26.5%, p = 
0.001), HTN (80.7% vs 61.1%, p = 0.001), history of CVA (17.8% vs 13.9%, p = 0.001), 
history of peripheral vascular disease (13.9% vs. 10.9%, p = 0.011), and history of CHF 
(27.5% vs 21.9%, p = 0.001). Whites were more likely than blacks to have COPD (21.1% 
vs 18.8%, p = 0.012) and to have had previous CABG (15.1% vs 10.8%, p = 0.001).  
Admission characteristics: Blacks had higher APACHE II scores (10.56 vs. 9.99, p = 
0.001), longer lengths of hospital stay (7.8 vs. 6.7 days, p = 0.34), and higher rates of 
CHF (33.6% vs. 29.0%, p = 0.006) compared to whites. Whites were more likely have Q-
wave MI (16.4% vs. 12.4%, p = 0.045), atrial fibrillation (11.7% vs 7.7%, p = 0.001), and 
left bundle branch block (7.2% vs 4.9%, p = 0.023) on initial EKG compared to blacks.  
Drop Outs / Loss to Follow Up: N/A 
Potential for selection bias: The black and white comparison groups had statistically significant 
differences for several variables. Attempts to control for these initial differences were made 
through multiple logistic regression models. Differences in treatment facility characteristics and 
access were not measured, and it is possible that the comparison groups differed in access to 
quality care. Other potential unknown and unaccounted for differences also may exist between 
 71 
the groups that were not accounted for in the analysis, though the list of the initial comparative 
variables is very extensive and includes patient characteristic, admission characteristic, and 
hospital stay characteristic variables.  
Measurement of intervention: PTCA, CABG, cardiac catheterization, multiple gated 
acquisition scan, stress test, and echocardiography as indicated by medical records.  
Measurement of outcomes: Events during hospitalization and mean time to procedure were 
indicated by medical records. 30-day mortality rates were obtained from databases of the Social 
Security Administration.  
Potential for measurement bias: Two contractors abstracted information on admitting 
variables, variables concerning hospital stay, and discharge variables from the CCP data records 
of those selected to be in the study. It is unclear if those abstracting chart information were aware 
of patient outcomes before conducting the chart review. The completeness, validity, and 
reliability of the CCP medical data is also unknown. No information is provided regarding the 
validity and reliability of the chart based racial classification used during the study, it is unclear 
if race/ethnic identification was self-designated or assigned. AMI identification was done 
through chart codes, and further supported through confirmation using specific predefined 
laboratory and clinical parameters during the chart review. No information is provided regarding 
the validity and reliability of using Social Security Administration databases to measure 30-day 
mortality.   
Potential confounders: Tables 1-3 list several potential confounders separated by patient 
characteristics, admission characteristics, and hospital stay characteristics.  
 
 72 
Potential for confounding: No systematic approach to the identification of potential 
confounders is described, though extensive comparisons on several patient related factors are 
provided and statistically adjusted for using regression models. The adequacy of using medical 
records to identify and measure these potential confounders is unknown. No information was 
collected on hospital treatment capabilities and access to quality of care. There were no measures 
of SES, and no controls for SES within the regression models. Though patients were all on 
Medicare, it is possible that much of the observed effect according to race would be accounted 
for by differences in SES.  
Analysis: Statistical significance of potential confounders was calculated using chi-square 
analysis for categorical variables and analysis of variance for continuous variables. Variables 
that were significant or borderline significant were included in multiple logistic regression 
models in which various procedures were the dependent variables and race or ethnicity was an 
independent variable along with other covariates.   
Results: Blacks were less likely to receive PTCA (12.7% vs 17.8%, p = 0.001) and CABG 
(4.6% vs 9.7%, p = 0.001). Blacks received PTCA less often than whites (OR = 0.64 95% CI 
0.49-0.85) and CABG less often than whites (OR 0.42 95% CI 0.27-0.64) after adjusting for age, 
sex, smoking, comorbidity, HTN, CVA, COPD, dementia, peripheral vascular disease, CHF, 
hemorrhage, rales, S3 gallop, chest pain during stay, duration of chest pain, atrial fibrillation, and 
left bundle branch block. Blacks had lower 30 day mortality compared to whites (OR 0.87 95% 
CI 0.59-1.27) after adjusting for age, sex, smoking, APACHE II scores, ejection fraction, 
comorbidities, various events after admission, hospital complications, and EKG abnormalities.  
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Overall judgment of internal validity: The extensive comparison of groups according to 
several variables, and the controlling for significant differences by regression modeling helps 
lower the potential for selection bias and confounding affecting internal validity of this study. 
Measurement bias remains a valid threat to the internal validity of this study, further reporting of 
the validity and reliability of several measures included within this study would further 
strengthen internal validity.  
Overall judgment of external validity: The external validity of this study is threatened by the 
selection of patients only from California hospitals. Geographic differences in acute myocardial 
infarction severity and treatment may limit the generalizability of this study. The inclusion of 
patients from a broader sample of treatment areas would increase the external validity of the 
study. Findings may also differ among younger populations.  
Overall conclusions/interpretations: The study results show that blacks were less likely than 
whites to receive revascularization after AMI. This difference remained after controlling for 
several patient and clinical variables. Despite this difference in treatment, blacks and whites had 
similar adjusted 30-day mortality rates. Significant effort was taken to minimize selection bias 
and confounding of the results. Further information on the adequacy of the measurement tools 
used for the study would strengthen findings.  
 
5. Citation: Giles W, Anda R, Casper M, et al. Race and sex differences in rates of invasive 
cardiac procedures in US hospitals. Archives of Internal Medicine. 1995; 155: 318-324. 
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Study Question: Do racial differences in cardiac procedure rates persist after matching for 
hospital of admission and adjusting for age, insurance, in-hospital mortality, and hospital transfer 
rates?  
Research design: Retrospective cohort study 
Study population: Patients over the age of 35 who were discharged from the hospital with a 
primary diagnosis of AMI between 1988-1990 and registered in the National Hospital Discharge 
Survey (NHDS).  
-12,837 eligible 
- Excluded if persons likely had MI ruled out and persons who race was reported as neither black 
nor white.  
- 10,348 patients included in study (5503 white men, 581 black men, 3786 white women, 478 
black women).  
Identification of race/ethnicity: Measured using NHDS data. 
Identification of AMI: Measured using ICD-9 CM codes from NHDS data.  
Initial comparability of groups: Black men, black women, white men, and white women 
differed according to age (64, 68 ,66, and 68 years), private insurance of Blue Cross (36.9%, 
18.0%, 36.4%, 17.3%), Medicare (51.4%, 64.7%, 58.2%, 77.7%), Medicaid or no insurance 
(11.7%, 17.4%, 5.5%, 5.0%), percent admitted to proprietary hospital (7.0%, 5.0%, 10.3%, 
11.3%), percent admitted to government hospital (20.2%, 15.5%, 9.6%, 11.1%), percent 
admitted to non-profit hospital (72.8%,79.4%, 80.1%, 77.6%), and region where care received: 
Northeast (20.5%, 18.7%, 26.1%, 30.2%), Midwest (12.1%, 18.4%, 26.9%, 25.6%), South 
(46.1%, 44.3%, 35.3%, 32.9%), and West (21.3%, 18.6%, 11.6%, 11.3%).  
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Drop Outs / Loss to Follow Up: N/A 
Potential for selection bias: Black and white patients differed according to age, type of health 
insurance, and region of care. These differences were controlled for with regression models 
during analysis. No comorbidity or MI severity variables were measured for, compared between 
groups, or controlled for during analysis.  
Measurement of intervention: Measured cardiac procedures using ICD-9 CM codes from 
NHDS data.  
Measurement of outcomes: Measured using discharge data from the NHDS. No other 
information source is indicated.  
Potential for measurement bias: There is no information on the reliability or validity of using 
the NHDS as a data source to measure patient variables, procedure utilization, or mortality. It is 
unclear how valid and reliable the determination of race was within the study, it is not clear if the 
data source reflected patient self reported or provider assigned identity.  
Potential confounders: Potential confounders considered were age, sex, race, patient disposition 
at discharge, insurance status, hospital size, hospital type, and geographic region of care.  
Potential for confounding: No systematic approach to the identification of potential 
confounders is described. Measured group variables are limited to patient age, sex, race, 
insurance status, and hospital size and type. There is no information regarding the comparisons 
of patient comorbidity or MI severity, and no adjustment is made for these variables during 
analysis. Measures of SES are limited to insurance status only, and SES differences may account 
for some of the differences seen according to race.  
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Analysis: Regression models were constructed to control for group differences. Matched 
analysis was also performed in which persons who underwent a cardiac procedure were matched 
with persons who were admitted to the same hospital but received no procedure. Separate 
matched analyses were undertaken for each cardiac procedure. Conditional logistic regression 
was used to calculate relative odds of having undergone PTCA or CABG for each race-sex 
group.  
Results: White men had the highest age adjusted rates of PTCA (8.8%), followed by white 
women (8.0%), black women (4.8%) and black men (3.3%). White men had the highest age 
adjusted rates of CABG (11.2%), followed by black men (6.7%), white women (6.7%), and 
black women (3.6%). Black women had the highest age adjusted in-hospital mortality (16.1%), 
followed by white women (15.7%), white men (14.6%), and black men (12.4%).   
Adjusted Odds Ratios for Invasive Cardiac Procedures:  
PTCA: White men (OR 1.0); black men (OR 0.35 95% CI 0.21-0.58), white women (OR 
0.94 95% CI 0.72-1.24), black women (OR 0.45 95% CI 0.19-1.03). 
CABG: White men (OR 1.0), black men (OR 0.50 95% CI 0.33-0.77), white  
women (0.54 95% CI 0.41-0.70), black women (0.26 95% CI 0.11-0.61).  
Overall judgment of internal validity: The limited number of variables measured, compared, 
and controlled for between black and white patients increases the potential for selection bias and 
confounding. The potential for measurement bias would be lowered if more information was 
given regarding the validity and reliability of measurement tools used during the study.  
 
 77 
Overall judgment of external validity: The study included a large national sample of patients 
from over 400 medical centers across the United States. The large national sample strengthens 
the generalizability of study findings.   
Overall conclusions/interpretations: The study shows that women and blacks are less likely to 
receive invasive cardiac procedures. Black women had the highest in-hospital mortality, while 
black men had the lowest in-hospital mortality. The results of the study may be limited by 
potential selection bias and confounding. The study design provides high generalizability of 
results to other populations.  
 
6. Citation: Gregory P, Rhoads G, Wilson A, et al. Impact of availability of hospital-based 
invasive cardiac services on racial differences in the use of these services. American Heart 
Journal. 1999; 138: 507-517. 
Study Question: Do racial discrepancies in the use of cardiac procedures exist according to 
availability at first hospitalization? Are there long term racial differences in outcomes?  
Research design: Retrospective cohort study 
Study population: Non-hispanic white and black patients age 30-99 discharged in 1993 with a 
primary diagnosis of AMI with zip code of residence in New Jersey registered in the Myocardial 
Infarction Data Acquisition System (MIDAS). 
- Excluded: Non-medicare patients and patients with AMI as non-primary diagnosis. 
- 13,690 met selection criteria (1217 blacks, 12,473 whites). 
Identification of race/ethnicity: Identified using hospital discharge data.  
Identification of AMI: Identified using ICD-9 CM codes from hospital discharge data.  
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Initial comparability of groups 
 Younger than 65 cohort: Blacks compared to whites were younger (53.6 vs. 54.6 years, 
p < 0.01), more likely to be female (40.6% vs. 24.7%, p < 0.01), more likely to be on Medicare 
(12.8% vs. 7.1%, p < 0.01), more likely to be on Medicaid (10.4% vs. 2.2%, p < 0.01), more 
often to self pay (20.3% vs. 10.1%, p < 0.01), had longer length of hospital stay (9.0 vs. 7.6 days, 
p < 0.01), lower 90 day readmission rates (34.6% vs. 67.5%, p < 0.01), had higher comorbidity 
scores (11.1 vs. 8.3, p < 0.01), less likely to have inferior infarct (30.9% vs. 40.8%, p < 0.01), 
more likely to have subendocardial infarct (33.8% vs. 25.8%, p < 0.01), more likely to present to 
hospital with catheterization available (52.2% vs. 46.1%, p < 0.01), and more likely to present to 
hospital with PTCA/CABG available (50.3% vs. 41.8%, p < 0.01).  
Older than 65 cohort: Blacks compared to whites were younger (75.8 vs. 76.9 years, p < 
0.01), more likely to be female (62.5% vs. 48.2%, p < 0.01), had longer length of hospital stay 
(12.0 vs. 10.3 days, p < 0.01), lower 90 day readmission (19.9% vs. 26.7%, p < 0.01), and more 
likely to present to hospitals with catheterization available (34.0% vs. 38.3%, p < 0.01).  
Drop Outs / Loss to Follow Up: N/A 
Potential for selection bias: Black and white comparison groups differed according to several 
measured variables. The groups were stratified according to age, and variable differences were 
controlled for using logistic regression models. Measured and accounted for variables included 
patient demographics, comorbidity, insurance type, and hospital care capabilities.  
Measurement of intervention: Procedures were measured using ICD-9 CM codes available 
through hospital discharge data.  
Measurement of outcomes: Mortality was measured using death certificates.  
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Potential for measurement bias: No information is provided regarding the validity and 
reliability of using hospital discharge data to identify race, it is unclear if this data uses self-
designated or assigned classifications. Using discharge data alone to measure patient clinical 
information may also limit validity and reliability.  
Potential confounders: Potential confounders considered were age, sex, insurance status, 
hospital stay, comorbidity, infarct location, and hospital cardiac care capability.  
Potential for confounding: No systematic approach to identifying potential confounders is 
described. Measured potential confounders were controlled for by stratifying analysis by age and 
logistic regression models. Only insurance status was used as an SES indicator, it is possible that 
some of the racial differences observed in the study are due to SES differences. Specific 
information regarding disease severity was not available, and infarct location was used as proxy 
for severity. It is possible that disease severity varied between the groups, and this explained 
some of the differences observed.  
Analysis: Chi-square tests and Wilcoxon rank sum tests were used to describe the distributions 
of variables and outcomes. Logistic regression models were constructed to control for potential 
confounding variables to study the use of cardiac procedures. Cox proportional hazards 
regression models were used to study 1 year mortality.  
Results: Adjusted rates showed blacks were less likely to receive revascularization than whites 
in both the younger than 65 cohort (OR 0.63 95% CI 0.52-0.76) and the older than 65 cohort 
(0.69 95% CI 0.54-0.86). Adjusted 1-year mortality rates showed no statistically significant 
difference between blacks and whites for the younger than 65 cohort (RR 0.85 95% CI 0.66-
1.09) or the older than 65 cohort (RR 1.03 95% CI 0.89-1.19).  
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Overall judgment of internal validity: Study design and statistical analysis help limit the 
overall potential for bias affecting study results. The unknown validity and reliability of some 
measurement tools used, as well as a remaining potential for confounding caused by single proxy 
measures for disease severity and SES may limit internal validity.  
Overall judgment of external validity: The study examined patients from a single geographic 
location, this significantly lowers the generalizability of findings.  
Overall conclusions/interpretations: Blacks were shown to receive revascularization 
procedures less often than whites after presenting with AMI. Despite this difference, there was 
no statistically significant difference in 1-year mortality. Study design and statistical analysis 
help limit the effects of bias within this study, but generalizability of findings is limited.  
 
7. Citation: Iribarren C, Tolstykh I, Somkin C, et al. Sex and racial/ethnic disparities in 
outcomes after acute myocardial infarction. Archives of Internal Medicine. 2005; 165: 2105-
2113.  
Study Question: Are there sex and racial/ethnic disparities in prognosis after AMI across men 
and women in the 4 main ethnic groups (white, black, Hispanic, Asian)? To what extent are these 
disparities explained by differences in socioeconomic background, personal medical history, and 
medical management? 
Research design: Prospective cohort study 
Study population: Patients age 30-85 years who were discharged from northern California 
hospitals after being hospitalized for AMI between 1995-2002. 
- 33,637 patients eligible 
- 86 excluded because hospital discharge was after Dec. 31, 2002 
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- 380 excluded because no health care plan information available after index event 
- 2,025 excluded because no available information on sex or race/ethnicity 
- 696 excluded because of absent or incomplete address 
- 117 were excluded because residency was outside northern California.  
- 9 were excluded because of missing census data. 
Patients included in study: 30,324 
Identification of race/ethnicity: Identified through research surveys (self-reported ethnicity 
used in 55% of cohort) and inpatient electronic records (assigned ethnicity).  
Identification of AMI: Identified by using ICD-9 CM codes available through computerized 
medical services utilization data and claims data.  
Initial comparability of groups:  
Male Sociodemographic: Blacks compared to whites were younger (61 vs. 64 years), 
more likely to have commercial insurance (67% vs. 48%), less likely to receive Medicare 
(29% vs. 45%), less likely to self pay (2% vs. 6%), less likely to be married (48% vs. 
54%), had lower annual household incomes ($51,886 vs. $60,373), had a higher 
percentage of households below the poverty line (12% vs. 9%), lower rate of completed 
college or high school education (25% vs. 31%), and a higher rate of working class 
occupations (64% vs. 58%). All differences were statistically significant (p < 0.001).  
Male Clinical Characteristics: Blacks compared to whites were more likely to have 
coronary heart disease (23% vs. 2%, p <0.001), higher rates of HTN (60% vs. 40%, p < 
0.001), higher rates of diabetes mellitus (35% vs. 24%, p < 0.001), higher rates of 
depression (27% vs. 23%, p < 0.001), higher rates of stroke history (9% vs. 5%, p < 
0.001), and higher rates of heart failure (9% vs. 5%, p < 0.001) 
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Female Sociodemographic: Blacks compared to whites were younger (64 vs. 69 years), 
more likely to have commercial insurance (52% vs. 32%), less likely to receive Medicare 
(41% vs. 63%), less likely to self pay (2% vs. 5%), less likely to be married (46% vs. 
54%), had lower annual household incomes ($47,865 vs. $59,388), had a higher 
percentage of households below the poverty line (14% vs. 8%), lower rate of completed 
college or high school education (22% vs. 30%), and a higher rate of working class 
occupations (66% vs. 58%). All differences were statistically significant (p < 0.001).  
Female Clinical Characteristics: Blacks compared to whites were more likely to have 
coronary heart disease (25% vs. 18%, p <0.001), higher rates of HTN (71% vs. 55%, p < 
0.001), higher rates of diabetes mellitus (42% vs. 29%, p < 0.001), higher rates of 
depression (35% vs. 34%, p < 0.001), higher rates of stroke history (9% vs. 5%, p = 
0.003), higher rates of asthma (17% vs. 15%, p = 0.03), and higher rates of heart failure 
(15% vs. 8%, p < 0.001).  
Drop Outs / Loss to Follow Up: None reported 
Potential for selection bias: Black and white comparison groups differed according to several 
demographic, clinical, and socioeconomic variables. Regression models were used to adjust for 
these differences during final analysis. No hospital characteristic information is provided. All 16 
hospitals included in the study are under the control of Kaiser Permanente, however, it is not 
made explicitly clear that all hospitals in the system are of similar care capability, and thus 
access to quality of care may have differed between groups. No participants appear to have been 
lost during follow up.  
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Measurement of intervention: Procedures measured using ICD-9 CM codes available through 
inpatient databases of hospitalizations occurring at any of the 16 KRMCP hospitals in northern 
California and out of plan hospitalizations using automated databases of claims.  
Measurement of outcomes: Mortality measured using the California Automated Mortality 
Linkage System. 
Potential for measurement bias: Race was measured using self-reported data along with the 
use of validated inpatient medical records (shown to have approximately 95% agreement with 
self-reported data in previous studies). Medical history data was measured using hospital 
discharge data, the validity and reliability of using discharge data alone to identify medical 
variables is not reported. Mortality was measured using the California Automated Mortality 
Linkage system, which has been shown to have a sensitivity of 97% compared with the National 
Death Index. SES indicators were measured using block census data, and may not accurately 
represent the cohort itself. It is unclear if chart data was reviewed by independent reviewers, and 
if researchers were masked to patient identity and race during the study.  
Potential confounders: Several potential confounders were addressed within the study including 
age, sex, comorbidities, SES status, and treatment differences.  
Potential for confounding: No systematic process to identify potential confounders is 
described. Several demographic and clinical variables were measured and adjusted for using 
regression models. Specific measures of disease severity were not included in the study. It is 
possible that the groups differed in disease severity, and this explained some of the observed 
differences in treatment and outcomes observed between groups. No hospital specific measures 
are provided, and it is possible that the comparison groups differed in their access to quality care 
during their index AMI admission.  
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Analysis: Bivariate analysis was performed using analysis of variance, Kruskall-Wallis 
nonparametric analysis of variance, and chi-square tests. A series of 3 proportional hazards 
regression models was used to model the association between joint categories of sex and 
race/ethnicity and hazard of AMI and all cause mortality.  
Results: Black men received revascularization procedures less often than white men (49% vs. 
63%, p<0.001). Black women received revascularization procedures less often than white 
women (41% vs. 48%, p < 0.001). Age adjusted risk of all-cause mortality was higher in black 
men (HR 1.55 95% CI 1.37-1.75) and black women (HR 1.45 95% CI 1.27-1.66) compared to 
white men. Age adjusted mortality rate/100 person years for males adjusted for age, insurance, 
sociodemographic factors was HR 1.34 (95% CI 1.18-1.52) and was HR 1.22 (95% CI 1.06-
1.40) for females. After adjusting for patient demographic information, clinical variables, and 
treatment black men (HR 1.02 95% CI 0.90-1.15) and black women (HR 0.82 95% CI 0.71-0.94) 
did not have significantly higher all cause mortality rates compared to white men.  
Overall judgment of internal validity: Study design and statistical analysis decreases the 
potential for bias to affect the internal validity of this study. A more complete comparison of 
disease severity between groups would further limit the potential for selection bias and 
confounding.  
Overall judgment of external validity: External validity is strengthened by the use a large 
racially diverse population. External validity is limited by the use of treatment centers and 
patient populations solely located in northern California. A broader geographic representation 
would improve the external validity of the study.  
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Overall conclusions/interpretations: The study shows that black men and women are less 
likely than white men to receive revascularization procedures after AMI. Black men and black 
women had higher age adjusted all-cause mortality rates compared to white men, however, no 
statistically significant difference remained after controlling for patient factors, SES, and clinical 
variables.  
8. Citation: Palmeri S, Lowe A, Sleeper L, et al. Racial and ethnic differences in the treatment 
and outcome of cardiogenic shock following acute myocardial infarction. American Journal of 
Cardiology. 2005; 96: 1042-1049. 
Research design: Retrospective cohort study 
Study population: Patients diagnosed with cardiogenic shock as the result of left ventricular 
failure that complicated AMI from 36 registry centers across the United States from 1993-1997 
from the SHould We emergently revascularize Occluded Coronaries for cardiogenic shocK 
(SHOCK) registry.  
- Total patients included: 538 (440 white, 34 black) 
Identification of race/ethnicity: Identified using information available through the SHOCK 
registry.  
Identification of AMI: Identified using information available through the SHOCK registry.  
Initial comparability of groups: Blacks compared to whites were younger (64.6 vs. 68.9 years, 
p = 0.001), had a higher rate of HTN (81.8% vs. 52.5%, p = 0.005), had longer median time from 
diagnosis of shock to PCI (4.6 vs. 2.7 hrs, p = 0.047), had higher diastolic blood pressure (57 vs. 
53 mm Hg, p = 0.017), and higher median creatine kinase/ULN (11.6 vs. 9.3, p = 0.013).  
Drop Outs / Loss to Follow Up: N/A 
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Potential for selection bias: Extensive comparisons are made between black and white patient 
groups according to medical history, disease severity, time to treatment, and presentation. Blacks 
compared to whites differed according to age, hypertension, time from shock diagnosis to PCI, 
diastolic blood pressure, and median creatine kinase levels. These differences were adjusted for 
during analysis. No comparisons were made between groups regarding hospital characteristics or 
SES. The small sample size (440 white and 34 black patients) may have been insufficient to 
detect all true differences between groups.  
Measurement of intervention: Cardiac procedures measured using data from the SHOCK 
registry. 
 Measurement of outcomes: Mortality measured using data available from the SHOCK registry.  
Potential for measurement bias: The process of compiling chart data for the SHOCK registry 
is not described, but available literature is cited. The cited literature along with this publication 
does not describe the reliability and validity of measures for race, patient and clinical variables, 
treatments, and mortality. It is unclear if chart reviewers were masked to patient identity, race, or 
outcome during the review.  
Potential confounders: Potential confounders considered were age, sex, smoking status, 
medical history/comorbidity, time to treatment, and admission vitals/cardiac laboratories.  
Potential for confounding: No systematic approach to identifying potential confounders is 
described. Regression models were used to control for measured group differences. Admission 
hospital characteristics and differences in SES were not measured or controlled for, and may 
account for some of the differences observed between the black and white patient groups.  
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Analysis: Comparisons across race and categorical variables were conducted using Fisher’s 
exact test. Comparisons between race and continuous variables were made using the 
nonparametric Kruskal-Wallis test. Multivariate modeling was conducted using logistic 
regression to compare race as an independent predictor of in-hospital moratlity.  
Results: Blacks diagnosed with left ventricular heart failure following AMI were less likely to 
receive any form of coronary revascularization (44.1% vs. 45.9%, p = 0.005) and less likely to 
receive coronary angioplasty (35.3% vs. 31.8%, p = 0.025) than whites. Adjusted in-hospital 
mortality rates showed black patients had higher mortality rates than white patients (OR 1.82 
95% CI 0.84-3.94), though the difference was not statistically significant.  
Overall judgment of internal validity: Internal validity may be limited by a potential for 
measurement bias caused by insufficient description of measurement tools and processes. 
Extensive group comparisons and large regression models help limit potential selection bias and 
confounding to affect internal validity.  
Overall judgment of external validity: The study population was limited to patients with 
cardiogenic shock caused by left ventricular failure. The selection of this very specific patient 
population limits generalizability to other patient populations.  
Overall conclusions/interpretations: The study results show that blacks compared to Whites 
diagnosed with cardiogenic shock caused by left ventricular failure that complicates AMI were 
less likely to receive any form of revascularization or coronary angioplasty. Differences in 
CABG alone were not statistically significant. Blacks compared to whites showed a trend toward 
higher adjusted in-hospital mortality rates, though the difference was not statistically significant. 
Potential for measurement bias may limit the accuracy of findings.   
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9. Citation: Petersen L, Wright S, Peterson E. Impact of race on cardiac care and outcomes in 
veterans with acute myocardial infarction. Medical Care. 2002; 40: I-86-I-96.  
Study Question: Are there racial differences in the use of medications and invasive procedures 
for acute myocardial infarction in the VA health care system? 
Research design: Retrospective cohort study 
Study population: Males with a primary diagnosis of AMI discharged from acute care VA 
facilities between 1994-1995.  
- 13,310 eligible patients 
- Sampled patients from the 13,310 eligible stratified by hospital cardiac service capability.  
- Stratified selected sample included 5503 patients. 
- 94.4% of those selected had available records. 
- Patients were excluded if they did not meet clinical criteria for AMI, were discharged to an 
acute care non-VA facility, or had incomplete chart information.  
- Study population included 4760 patients (4,005 white, 606 black, 149 other) 
Identification of race/ethnicity: Determined by using chart documentation in medical record.   
Identification of AMI: Identified by International Classification of Diseases 9
th
 revision of AMI 
and confirmed through chart review for necessary clinical criteria.  
Initial comparability of groups: Blacks compared to whites were more likely to present to the 
hospital after the start of chest pain (34.4% vs. 27.7% for >12 hrs, p = 0.005), had a higher rate 
of CHF (21.4% vs. 15.4%, p <0.001), had lower rates of previous MI (29.4% vs. 35.5%, p = 
0.003), had higher rates of HTN (75.2% vs. 58.6%, p <0.001), had lower rates of COPD (18.0% 
vs. 27.3%, p <0.001), higher rates of previous stroke (18.6% vs. 15.5%, p = 0.04), and had lower 
rates of previous CABG (7.8% vs. 18.4%, p <0.001).  
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Drop Outs / Loss to Follow Up: N/A 
Potential for selection bias: Black and white patients differed according to time of presentation 
after onset of chest pain, prevalence of CHF, prior MI, HTN, COPD, history of stroke, and prior 
CABG. Logistic regression models were used to control for significant group differences. Other 
potential unknown and unaccounted for differences may exist between the groups that were not 
included in the analysis. 
Measurement of intervention: Assessed use of angioplasty or CABG during index 
hospitalization as well as in the 90 days after the index admission in any VA facility or under 
Medicare financing using medical records.  
Measurement of outcomes: Mortality was measured using the medical chart, inpatient 
discharge status from VA Patient Treatment File, the VA Beneficiary Identification and Record 
Location Subsystem, and the Medicare Denominator File.  
Potential for measurement bias: Data abstraction of patient records by trained nurses showed a 
96% agreement for collected clinical variables. No information is provided that indicates the 
reliability and validity of the chart based racial identification used for the study, it is unclear if 
identification was self-designated or assigned. Measurement of procedure utilization included 
both VA and Medicare records to account for veterans receiving procedures under Medicare 
funding. Four different sources were used to measure mortality (including VA and Medicare 
files), but no information is provided regarding the validity and reliability of any of the sources. 
It is unclear if chart reviewers were masked to patient identity and race while collecting data.  
Potential confounders: Potential confounders considered were age, time to presentation after 
onset of chest pain, blood pressure, CHF, prior MI, HTN, DM, COPD, peripheral arterial 
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disease, history of stroke, prior CAGB, prior PTCA, and discharged against medical advice 
status.  
Potential for confounding: No systematic approach to the identification of potential 
confounders is described. Potential confounders identified in the study were controlled for by 
using regression models. Hospital variables were not directly measured, but the selection of 
patients was stratified according to hospital cardiac care capability. SES indicators were not 
measured. Male veterans were selected with the goal of limiting SES differences between 
patients.  
Analysis: Chi-square and t-tests were used to examine differences between black and white 
patients. Logistic regression was used to calculate the risk adjusted odds of mortality for blacks 
compared to whites.  
Results: Blacks did not receive PTCA significantly less often than whites during index 
hospitalization (12.5% vs. 11.6%, p = 0.51) or within 90 days of index admission (15.4% vs. 
15.4%, p = 0.96). Blacks did receive CABG less often than whites during the index 
hospitalization (3.6% vs. 7.0%, p <0.01) and within 90 days of index admission (6.9% vs. 
12.5%, p <0.001). Blacks were slightly less likely to receive any revascularization during the 
index admission, though this difference did not achieve statistical significance (15.2% vs. 18.2%, 
p = 0.07). Blacks were less likely to receive revascularization than whites within 90 days of 
index admission (20.8% vs. 26.9%, p = 0.001). Crude 30 day mortality (13.1% vs. 12.4%, p = 
0.61), 1 year mortality (23.3% vs. 23.8%, p = 0.76), and 3 year mortality (37.7% vs. 36.8%, p = 
0.68) did not show statistically significant difference between black and white patients 
respectively. After adjusting for age, hospital type, comorbidity, prior angioplasty, and 
complications, 30 day mortality (OR 0.99 95% CI 0.74-1.3), 1 year mortality (OR 0.86 95% CI 
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0.68-1.09), and 3 year mortality (0.93 95% CI 0.76-1.15) for blacks compared to whites 
remained similar.  
Overall judgment of internal validity: The described study design and analysis significantly 
lowers the potential for bias to compromise internal validity of the study. Further reporting on 
the validity and reliability of measurement tools, a more extensive comparison of groups 
according to clinical factors, and larger regression models would strengthen the findings.  
Overall judgment of external validity: External validity is strengthened by the fact that the 
study used a national sample of patients from 81 veteran hospitals across the US of varying 
cardiac care capabilities. External validity may be limited because the study only included male 
veterans.  
Overall conclusions/interpretations: Blacks were shown to receive CABG less often than 
whites, but received PTCA at similar rates. Despite differences in procedure utilization, their 
were no significant differences in 30 day, 1 year, and 3 year mortality. Improved reporting on the 
validity and reliability of measurement tools and the assessment of SES as a potential confounder 
would strengthen findings.   
 
10. Citation: Peterson E, Wright S, Daley J, Thibault G. Racial variation in cardiac procedure 
use and survival following acute myocardial infarction in the Department of Veterans Affairs. 
JAMA. 1994; 271: 1175-1180.  
Study Question: Are blacks admitted to Veterans Affairs Medical Centers with acute 
myocardial infarction less likely than whites to undergo cardiac catheterization and 
revascuarlization procedures? If differences exist, how do they impact patient survival?  
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Research design: Retrospective cohort study 
Study population: Male veterans discharged from Veteran Affairs Medical Centers (VAMC) 
with a primary or secondary diagnosis of AMI between 1988-1990.  
51,585 eligible patients. 
- Excluded if Hispanic/white, Hispanic/black, Native American, or Asian/Pacific Islander (2426 
patients).  
- Excluded if first surgical procedure during hospitalization was not for cardiac surgery, cardiac 
catheterization, PTCA, or minor cardiac procedures (2838 patients).  
- Excluded if had a diagnosis of AMI and a length of stay less than 5 days and discharged alive 
(“rule out AMI’s”) (5863 patients).  
- Excluded if previous AMI within 365 days (4459  patients).  
- Excluded if PTCA, CABG, or cardiac catheterization within 90 days prior to admission for 
AMI (1099 patients) 
- Excluded patients with lengths of stay greater than 180 days (261 patients).  
- Excluded patients with a recent AMI admitted for subsequent care within 8 weeks of the acute 
episode (994 patients).  
33,641 patients included (29,119 white, 4522 black).  
Identification of race/ethnicity: Identified using patient data from the Veterans Health 
Administration Patient Treatment File database.  
Identification of AMI: Identified using ICD-9-CM codes available from Veterans Health 
Administration Patient Treatment File database.  
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Initial comparability of groups: Blacks compared to whites were younger (63.0 vs. 64.4 years, 
p< 0.05), had fewer cardiac complications (58.6% vs. 53.4%, p < 0.05), were less likely to 
present to a hospital without a cardiac catheterization laboratory ( 20.0% vs. 36.5%, p < 0.05), 
and more likely to present to a hospital with a cardiac catheterization laboratory and cardiac 
surgery program (52.4% vs. 44.6%, p < 0.05).  
Drop Outs / Loss to Follow Up: N/A 
Potential for selection bias: Black and white comparison groups differed according to cardiac 
complications and hospital characteristics of index admission. Regression models were 
constructed to adjust for these differences during analysis. Comorbidity comparisons are limited 
to number of secondary diagnoses, it is possible that the groups differ significantly according to 
individual comorbidity status. No SES indicators are compared between groups. Participants are 
all veterans with likely comparable health and economic benefits, but differences in 
supplemental insurance, income, education, etc. may still exist between groups. Characteristics 
of admitting hospitals are compared and controlled for during analysis.  
Measurement of intervention: Cardiac procedures measured using ICD-9-CM codes available 
through the Veterans Health Administration Patient Treatment File database.  
Measurement of outcomes: Mortality measured using the Beneficiary Identification and Record 
Locator System.  
Potential for measurement bias: The validity and reliability of using veteran treatment files to 
measure race is not reported, it is unclear if information collected reflects self-designated or 
provider assigned race. The validity and reliability of using this database to measure patient, 
clinical, and procedural variables is also not reported. Researchers did perform a random full 
medical chart review of 1000 patients to compare database AMI diagnosis with cardiac enzyme 
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and electrocardiogram confirmation from medical records. The diagnosis of AMI was clinically 
confirmed in 88% of cases. The Beneficiary Identification and Record Locator System used to 
measure mortality is reported to have 98% concordance with Medicare’s Health Skeletonized 
Eligibility Writeoff data in more than 98% of cases. It is unclear if chart reviewers were masked 
to patient identity and race.  
Potential confounders: Potential confounders included were age, cardiac complications, 
secondary diagnoses, year of AMI, hospitalized within previous year, and characteristics of 
index hospital of admission.  
Potential for confounding: No systematic approach to identifying potential confounders is 
described. The comorbidity data provided only includes number of secondary diagnoses. It is 
possible that patients may have the same number of secondary diagnoses but differ in prognosis 
based upon the specific collection of diagnoses themselves. Both primary and secondary AMI 
diagnoses were included in this study. It is possible that outcomes attributed to AMI in patients 
with a secondary diagnosis of AMI were more associated with their respective primary 
diagnosis. It is unclear if black and white patients differed in the proportion of patients diagnosed 
with primary and secondary AMI. No specific SES indicators are measured or controlled for. 
Veterans were selected specifically to limit differences in access to quality care, however, SES 
differences may  still exist between black and white veterans that may explain some of the racial 
differences in treatments and outcomes.  
Analysis: Chi-square and t-tests were used to analyze the relationship between patient and 
hospital characteristics to race. Logistic regression models were constructed to determine the 
effect of race on the use of cardiac procedures. Likelihood ratios for the effect of race on 30-day, 
1-year, and 2-year survival were calculated.  
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Results 
Unadjusted procedure rates and morality: Blacks compared to whites received PTCA 
(4.2% vs. 6.2%, p<0.0001) and CABG (5.1% vs. 9.6%, p < 0.0001) less often. Blacks 
received any form of revascularization less often than whites (9.0% vs. 15.3%, p < 
0.0001). Blacks had higher 30 day (OR 1.21 95% CI 1.11-1.21), 1 year (OR 1.11 95% CI 
1.04-1.19), and 2 year (1.05 95% CI 0.99-1.12) survival compared to whites. 
Adjusted procedure rates and mortality: Blacks compared to whites received PTCA 
(OR 0.58 95% CI 0.48-0.66) and CABG (0.46 95% CI 0.40-0.53) less often than whites. 
Blacks received any form of revascularization less often than whites (OR 0.46 95% CI 
0.41-0.52). Blacks had higher 30 day (OR 1.18 95% CI 1.07-1.31), 1 year (OR 1.07 95% 
CI 0.99-1.16), and 2 year (OR 1.01 95% CI 0.92-1.07) compared to whites, though 1 and 
2 year survival differences did not achieve statistical significance. Model adjusted for 
age, cardiac complications, number of secondary diagnoses, hospitalization in the 
previous year, characteristics of index hospital, and year of discharge.  
Overall judgment of internal validity: Study design and analysis help limit the effects of bias 
within this study. Potential unmeasured differences in comorbidity status and SES between black 
and white patient groups may confound results and decrease internal validity.  
Overall judgment of external validity: External validity is strengthened by the large study 
population from VA medical facilities across the United States. The study population consisted 
of only males, and results may not  be generalizable to female patients.  
Overall conclusions/interpretations: The study results indicate blacks receive revascularization 
procedures after AMI less often than whites. Blacks compared to whites have better 30 day 
survival after AMI, but no differences in survival are seen at 1 and 2 years. Study results may be 
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limited by unmeasured potential differences in comorbidity and socioeconomic status between 
blacks and whites.  
11. Citation: Maynard C, Litwin P, Martin J, et al. Characteristics of black patients admitted to 
coronary care units  in metropolitan Seattle: Results from the myocardial infarction triage and 
intervention registry (MITI). American Journal of Cardiology. 1991; 67: 18-23.  
Study Question: Do black and white patient AMI populations differ according to baseline and 
clinical features, AMI treatment, and outcome?  
Research design: Prospective cohort study 
Study population: Patients admitted to coronary care units for chest pain in 19 hospitals in 
metropolitan Seattle between 1988-1990 contained within the Myocardial Infarction Triage and 
Intervention (MITI) registry database. 
- 14,283 total patients admitted for chest pain 
- 1749 excluded because of missing race data or race other than black or white. 
- Of the remaining 12,534 patients, 2,870 patients were diagnosed with AMI. 
- AMI cohort included 2,870 patients (2749 white and 121 black)  
Identification of race/ethnicity: Identified through medical chart data. 
Identification of AMI: Identified through hospital discharge data.   
Initial comparability of groups: Blacks compared to whites were younger (59 vs. 67 years, p 
<0.0001), more likely to be admitted to Central City Hospital (69% vs. 33%, p<0.0001), and 
more likely to have HTN (67% vs. 46%, p<0.0001).  
Drop Outs / Loss to Follow Up: None reported 
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Potential for selection bias: Black and white patients differed according to age, admission to 
Central City Hospital, and HTN. No group comparisons are made according hospital 
characteristics or SES. Minimal comorbidity and risk factor comparisons are made, most notably 
the prevalence of diabetes and smoking status is not compared between the groups.  
Measurement of intervention: Cardiac procedures were measured using patient hospital 
records. 
 Measurement of outcomes: Mortality was measured using patient hospital records.  
Potential for measurement bias: Little information is provided on the details of the data 
collection process used for the study. It is unclear how comprehensive the review process was. 
The reliability and validity of information sources is not described. The validity and reliability of 
measures for race, cardiac procedures, and mortality is not described.  
Potential confounders: Potential confounders considered were age, sex, admission to Central 
City Hospital, medical history, admission symptoms, and time to treatment.  
Potential for confounding: No systematic approach to identifying potential confounders is 
described. No differences in hospital characteristics or SES status is measured or adjusted for 
during analysis. Comorbidity and risk factor comparisons are limited. Logistic regression models 
were used to control for measured differences.  
Analysis: Chi-square tests and t-tests were used to test for differences between race and 
measured variables. Multiple stepwise logistic regression was used to determine whether race 
was associated with mortality for AMI.  
Results: Blacks compared to whites received angioplasty (12% vs. 18%, p = 0.026) and 
coronary artery surgery (5% vs. 10%, p = 0.042) less often. Hospital mortality was 7.4% for 
black and 13.1% for white patients (p = 0.07).  
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Overall judgment of internal validity: Internal validity is severely limited by potential 
selection, measurement, and confounding biases. More detailed group comparisons and more in 
depth reporting of measurement tools and processes may strengthen the internal validity of 
results.  
Overall judgment of external validity: The study is limited to 19 hospitals in Seattle, WA and 
therefore has limited generalizability to other regions of the United States with varying patient 
and medical characteristics.  
Overall conclusions/interpretations: The study results show that blacks receive angioplasty 
and coronary artery surgery less often than whites. Despite this difference in treatment, blacks 
have lower hospital mortality than whites. Study findings are severely limited by potential 
selection, measurement, and confounding bias.  
 
 12. Citation: Maynard C, Every N, Martin J, Weaver W. Long-term implications of racial 
differences in the use of revascularization procedures (the Myocardial Infarction Triage and 
Intervention Registry). American Heart Journal. 1997; 134: 656-662. 
Study Question: Does the less intensive use of revascularization procedures influence the long-
term survival of black patients who were hospitalized for AMI in metropolitan Seattle.  
Research design: Retrospective cohort study 
Study population: Patients admitted to coronary care units in 19 hospitals in metropolitan 
Seattle with discharge diagnosis of AMI between 1988-1994 contained within the Myocardial 
Infarction Triage and Intervention (MITI) registry database. 
- Patients who had cardiac arrest at admission were excluded. 
- Patients who had AMI develop while hospitalized for another medical condition were excluded. 
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- Non-black and non-white patients were excluded.  
- Study included 420 blacks, 10,834 whites.  
Identification of race/ethnicity: As indicated in the MITI registry  
Identification of AMI: As indicated in the MITI registry 
Initial comparability of groups: Blacks compared to whites were younger (60 vs. 66 years, 
p<0.0001), less educated (22% vs 13% non-high school graduates; 29% vs 36% college 
graduates, p <0.0001), had lower household income (27.9 thousand vs. 38.2 thousand, p 
<0.0001), more likely to be unemployed (6% vs. 3%, p <0.0001), more likely to be on Medicaid 
(13% vs. 3%, p<0.0001), more likely to have HTN (67% vs. 46%, p < 0.0001), more likely to 
have DM (36% vs. 19%, p < 0.0001), and less likely to have had previous bypass surgery (6% 
vs. 10%, p = 0.004).  
Drop Outs / Loss to Follow Up: N/A 
Potential for selection bias: Black and white patients differed according to age, education, SES 
indicators, HTN, diabetes and history of previous heart surgery. Regression models were 
constructed to control for significant differences in patient variables. Other potential unknown 
and unaccounted for differences may exist between the groups that were not included in the 
analysis.  
Measurement of intervention: Procedures measured using the MITI registry during index case, 
rehospitalization procedures identified using International Classification of Diseases version 9 
diagnosis and procedure codes from the Washington hospital discharge abstract program.  
Measurement of outcomes: Mortality measured using MITI registry, the National Death Index, 
and state of Washington death certificates.  
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Potential for measurement bias: No information is provided regarding the validity and 
reliability of using the MITI registry to measure patient and clinical variables or using the 
National Death Index and Washington state death records to measure post-hospitalization 
mortality. No information is provided regarding the validity and reliability of the chart based 
racial classification used during the study, it is unclear if race/ethnic identification was self-
designated or assigned. It is unclear if researchers were masked to patient identity and race while 
performing the study.   
Potential confounders: Potential confounders considered were sge, sex, SES aggregate 
indicators, insurance, comorbidities, and smoking status.  
Potential for confounding: No systematic approach to the identification of potential 
confounders is described; those identified are statistically adjusted for using regression models. 
The reliability and validity of using the MITI registry to measure potential confounders is 
unknown. SES indicators were developed from aggregate US census data and described census 
blocks in which patients lived. It is possible that the SES variables do not appropriately reflect 
the true status of patients enrolled in the study. Hospital characteristics were limited to either 
“central city” or “suburban” classification, no further indications of treatment capability or 
quality of care is included in the analysis.  
Analysis: Racial differences in procedure use and mortality were adjusted for age and compared 
with logistic regression models. The log rank statistic was used to determine if survival differed 
between blacks and whites, and Kaplan Meier survival curves were constructed. Stepwise Cox 
regression analysis was used for all patients to determine if race was an independent predictor of 
survival. Statistically significant predictors were entered into the model, and race or 
revascularization procedures were forced into the model to determine association with survival.  
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Results:  
Hospital Treatment and Outcomes: Blacks received angioplasty (18% vs. 26%, p = 
0.0004) and CABG (7% vs 12%, p = 0.002) less often than whites. Overall 22% of blacks 
had a revascularization procedure compared to 33% of whites ( p <0.0001). After 
controlling for use of cardiac catheterization, percent professionals in the census block, 
prior coronary surgery, history of  angina, the use of  thrombolytic therapy, sex, and 
history of CHF, blacks were less likely to undergo revascularization (OR 0.60 95% CI 
0.45-0.81). Hospital mortality was slightly lower in blacks (OR 0.71 95% CI 0.50-1.04), 
though age adjusted hospital mortality showed no difference between the groups (OR 
1.05 95% CI 0.72-1.54).  
Long-term survival: Unadjusted 2 year survival was 79% for blacks and 77% for whites 
(p = 0.12). After controlling for all statistically significant variables except 
revascularization, there was no significant association between race and survival (Hazard 
Ratio 1.17 95% CI 0.94-1.45).  
Overall judgment of internal validity: The potential for selection bias limits the internal 
validity of the study. Data comparing the actual group participants in the study are limited to age 
and comorbidities. Comparative SES measures including insurance and education were derived 
from census block data, and may not accurately reflect participants. Findings would be 
strengthened if more information was provided regarding the validity and reliability of all 
measurements. The statistical power of the study to detect survival difference regarding race and 
revascularization is also limited due to a lower number of black participants.  
Overall judgment of external validity: Only patients from hospitals surrounding Seattle, 
Washington were selected. Geographic differences in disease and treatment may limit the 
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genralizability of the results. The inclusion of patients from a broader sample of treatment areas 
would increase the external validity of the study.  
Overall conclusions/interpretations: Blacks were significantly less likely than whites to 
receive PTCA or CABG after AMI. Despite these differences in treatment, no significant 
differences were observed in either short-term or long-term mortality. Study results may be 
limited by a potential for selection bias created by limited group comparative data.  
 
13. Citation: Mickelson J, Blum C, Geraci J. Acute myocardial infarction: Clinical 
characteristics, magnagement and outcome in a metropolitan veterans affairs medical center 
teaching hospital. Journal of the American College of Cardiology. 1997; 29: 915-925.  
Study Question: Do race and age influence the use of thrombolytic therapy, invasive cardiac 
procedures, and subsequent outcomes in a Veterans Affairs teaching hospital? 
Research design: Retrospective cohort study 
Study population: Patients admitted to Houston Veterans Affairs Medical Center between 
1993-1995 diagnosed with AMI.  
- 353 patients were included in the study (232 white, 84 black, and 37 Hispanic).  
Identification of race/ethnicity: Identification made by medical chart data.  
Identification of AMI: Identified by chart review for clinical presentation, cardiac enzymes, and 
EKG changes.  
Initial comparability of groups: Black and white patients were significantly different only 
according to COPD comorbidity (whites 20.7% vs. blacks 4.8%, p = 0.001) and aspirin 
prescription (20.7% vs. 88%, p <0.05). Patient age, cardiac enzyme, MI location, 
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revascularization, and other medical comorbidities and treatments were not significantly 
different between the groups.  
Drop Outs / Loss to Follow Up: N/A 
Potential for selection bias: The lack of comparative differences between the black and white 
comparison groups may suggest insufficient power to detect statistically significant differences 
between groups. Several studies have shown that blacks presenting with AMI tend to be younger, 
receive revascularization procedures less often, and also have higher rates of HTN and diabetes 
than white patients. The fact that none of these common differences were observed in this study, 
along with a study population of only 353 patients, may suggest insufficient group size to detect 
difference.  
Measurement of intervention: Measured by medical record review.  
Measurement of outcomes: Hospital survival was measured using medical records. The means 
of measuring post-hospitalization mortality is not specified.  
Potential for measurement bias: Patient presentation variables were collected directly from 
medical charts. Comorbid information was collected from the Veterans Affairs Treatment File 
database, the validity and reliability of using this database to measure comorbidities is not 
described. Means of racial identification are unclear. The measurement tools to assess post-
hospitalization mortality are unclear. It is unclear if chart reviewers were aware of patient 
identity or race during the study.   
Potential confounders: Potential confounders considered were age, cardiac enzymes, MI 
location, procedure, medication management, and medical comorbidities.  
Potential for confounding: No systematic approach to the identification of potential 
confounders is described. Potential confounders used may be inappropriately compared between 
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the groups due to insufficient sample sizes to detect valid differences. Logistic regression was 
used to control for significant variables identified. There were no measures of SES, and no 
controls for SES within the regression models. Some of the differences based on race may be 
explained by differences in SES.  
Analysis: Logistic regression was used to determine the relation between patient characteristics 
and mortality. Model construction was performed using a hierarchic approach; age and race were 
included in all models, and individual comorbid conditions were examined if they were 
univariately associated with mortality.  
Results: Blacks did not receive PTCA (17% vs. 23.3%) or CABG (7.1% vs. 10.3%) at rates 
significantly different from whites. In-hospital (14.3% vs. 10.3%) and 22-month mortality 
(30.9% vs. 23.3%) also showed no statistically significant differences between blacks and whites 
respectively.  
Overall judgment of internal validity: The internal validity of the study is significantly 
threatened by potential selection bias and confounding as described above.  
Overall judgment of external validity: The external validity of the study is significantly 
threatened by a small study population from a single hospital.  
Overall conclusions/interpretations: The study shows no statistically significant difference in 
revascularization procedures or mortality between black and white patients diagnosed with AMI. 
The findings are severely limited based on a strong potential for selection bias and confounding.  
 
14. Citation: Taylor H, Canto J, Sanderson B, et al. Management and outcomes for black 
patients with acute myocardial infarction in the reperfusion era. American Journal of Cardiology. 
1998; 82: 1019-1023.   
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Study Question: Do black patients presenting with acute myocardial infarction experience 
differences in treatment and in-hospital mortality?  
Research design: Retrospective cohort study 
Study population: Black and white patients diagnosed with AMI and enrolled in the National 
Registry of Myocardial Infarction 2 (NRMI 2) between 1994-1996. 
- Non-black minorities or those of unknown racial background were excluded.  
- 275,046 selected for study (236,166 white, 17,141 black). 
Identification of race/ethnicity: Specific means of race identification is unclear.  
Identification of AMI: Identified using predetermined cardiac enzyme changes, EKG changes, 
and ICD-9 CM coding.  
Initial comparability of groups:  
Demographic Information: Blacks compared to whites were younger (63 vs. 67 years, p 
< 0.001), more likely to be female (46% vs. 37%, p < 0.001), less likely to have 
commercial insurance (19% vs. 24%, p < 0.001), more likely to be on Medicaid (8% vs. 
2%, p < 0.001), more likely to be uninsured (9% vs. 5%, p < 0.001), more likely to have 
history of CHF (15% vs. 12%, p < 0.001), more likely to have diabetes (34% vs. 24%, p 
< 0.001), more likely to have HTN (68% vs. 48%, p < 0.001), more likely to be current 
smokers (32% vs. 28%, p < 0.001), less likely to have history of high cholesterol (19% 
vs. 24%, p < 0.001), and less likely to have a family history of coronary artery disease 
(23% vs. 31%, p < 0.001).  
Presenting characteristics: Blacks compared to whites were less likely to present with 
chest pain (72% vs. 76%, p < 0.001), had higher initial systolic blood pressure (148 vs. 
142, p < 0.001), less likely to have ST-segment elevation (40% vs. 46%, p < 0.001), more 
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likely to have non-specific EKG changes (37% vs. 31%, p < 0.001), less likely to have Q-
wave infarction (46% vs. 54%, p < 0.001), more likely to have non-Q wave infarction 
(54% vs. 46%, p < 0.001), and less likely to have an admission diagnosis of MI (40% vs. 
48%, p < 0.001).  
Hospital characteristics: Blacks were more likely to present to large hospitals that were 
more likely to have on site coronary angioplasty and CABG compared to whites. (As 
stated in text, actual rates not provided in text or tables).  
Drop Outs / Loss to Follow Up: N/A 
Potential for selection bias: Black and white patients differed according to several demographic 
and presenting characteristics as described above. Significant differences were controlled for 
with regression models. No specific information is given regarding differences in the 
characteristics of admitting hospitals, although multivariate analysis claims to account for 
“hospital characteristics”. The exact hospital differences measured and adjusted for are unclear. 
Without this information it is unclear if group differences in hospital of care exist, and if this 
difference accounts for any differences in outcome.  
Measurement of intervention: Measured using data from the NRMI2 registry.  
Measurement of outcomes: Specific means of measuring mortality is unclear.  
Potential for measurement bias: Several quality assurance mechanisms are described for the 
NRMI2 registry, but no specific information is provided regarding the validity, reliability, and 
completeness of medical information within this registry. The specific tools used to measure race 
for this study are unclear. The specific tools used to measure mortality for this study are unclear.   
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Potential confounders: Potential confounders considered were several patient variables 
including patient demographics, insurance status, cardiac risk factors, presentation, and 
laboratory findings.  
Potential for confounding: No systematic approach to the identification of potential 
confounders is described, though a broad and extensive list of potential confounders are 
measured and adjusted for. The validity and reliability of using the NRMI2 to measure potential 
confounders is unknown. Hospital cardiac care capabilities were not reported, though they are 
indicated to be controlled for in regression models. The NRMI2 is a voluntary registry, and is not 
randomized sample of MI patients. Several unknown and unmeasured potential confounders may 
be associated with being in the registry.  
Analysis: Chi-square tests, analysis of variance, non-parametric median tests, and Wilcoxon 
rank-sum tests were used to compare variables between groups. Multivariate logistic analyses 
was used to identify and control for variables predictive of utilizing invasive cardiac procedures 
and mortality.  
Results: Blacks were found to receive primary angioplasty at lower rates compared to whites 
(OR 0.84 95% CI 0.79-0.89). Blacks were less likely to receive “non-primary” angioplasty (OR 
0.83 95% CI 0.80-0.86) and CABG (OR 0.66 95% CI 0.63-0.68). Adjusted in-hospital mortality 
was not significantly different between black and white patients (as stated in results section, 
actual rates not provided in text or tables).  
Overall judgment of internal validity: The internal validity of the study is severely threatened 
by a high potential for measurement bias. Complete information regarding the key measures of 
racial identity and mortality is not provided. Both of these measures are critical to the assessment 
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of racial differences in hospital mortality, one of the primary research questions of the paper. 
Selection bias and confounding may also limit the internal validity of results.  
Overall judgment of external validity: The NRMI2 is a large patient registry representing 
more than 1400 medical centers located in every state of the US. It is a voluntary registry, and 
therefore may represent patients who differ fundamentally than those not included in the registry. 
The NRMI2 also includes a disproportionate number of technologically advanced medical 
centers. The limitations may lower the generalizability of findings based on registry data.  
Overall conclusions/interpretations: Blacks compared to whites presenting with AMI received 
primary angioplasty, non-primary angioplasty and CABG less often. In-hospital mortality was 
similar between the groups. Study results may be limited by a strong potential for measurement 
bias created by insufficient reporting of the key measures of race and mortality.  
 
 
 
 
 
 
 
 
